Intergenerational Effects of Nicotine in an Animal Model of Paternal Nicotine Exposure by Vallaster, Markus Parzival
University of Massachusetts Medical School 
eScholarship@UMMS 
GSBS Dissertations and Theses Graduate School of Biomedical Sciences 
2017-08-07 
Intergenerational Effects of Nicotine in an Animal Model of 
Paternal Nicotine Exposure 
Markus Parzival Vallaster 
University of Massachusetts Medical School 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/gsbs_diss 
 Part of the Behavioral Neurobiology Commons, Biochemical Phenomena, Metabolism, and Nutrition 
Commons, Cell Biology Commons, Cellular and Molecular Physiology Commons, Developmental 
Neuroscience Commons, Genetics Commons, Molecular Genetics Commons, and the Other 
Pharmacology, Toxicology and Environmental Health Commons 
Repository Citation 
Vallaster MP. (2017). Intergenerational Effects of Nicotine in an Animal Model of Paternal Nicotine 
Exposure. GSBS Dissertations and Theses. https://doi.org/10.13028/M2W388. Retrieved from 
https://escholarship.umassmed.edu/gsbs_diss/913 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in GSBS Dissertations and 
Theses by an authorized administrator of eScholarship@UMMS. For more information, please contact 
Lisa.Palmer@umassmed.edu. 
INTERGENERATIONAL EFFECTS OF NICOTINE IN AN ANIMAL MODEL OF 
PATERNAL NICOTINE EXPOSURE 
 
A Dissertation Presented 
By  	
MARKUS PARZIVAL VALLASTER 
 
Submitted to the Faculty of the  	
University of Massachusetts Graduate School of Biomedical Sciences, Worcester 
in partial fulfillment of the requirements for the degree of 
DOCTOR OF PHILOSOPHY 
August 7th, 2017 
 
INTERDISCIPLINARY GRADUATE PROGRAM 
 
  
	A Dissertation Presented By 
MARKUS PARZIVAL VALLASTER 
This work was undertaken in the Graduate School of Biomedical Sciences 
(Interdisciplinary Graduate Program) 
Under the mentorship of 
Oliver J. Rando, MD, PhD, Thesis Advisor 
 
 
Paul D. Gardner, PhD, Member of Committee 
 
 
Andrew R. Tapper, PhD, Member of Committee 
 
 
David Weaver, PhD, Member of Committee 
 
 
Mary-Elizabeth Patti, MD, External Member of Committee 
 
 
Ingolf Bach, PhD, Chair of Committee 
 
 
Anthony Carruthers, PhD,	Dean of the Graduate School of Biomedical Sciences 
 
 
August 7th, 2017 
	 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[This page is intentionally left blank] 
	 iv	
 
 
 
 
 
 
 
This work is dedicated  
To  
Caroline and Josephine 
With perpetual love and gratitude 
 
  
	 v	
Acknowledgements 
I would like to express my gratitude to my mentor Oliver J. Rando, whose wealth of 
knowledge and rigorous scientific thinking have been a continuous stimulus to be 
curious, to strive for the most ambitious projects, design the best experiments, and subject 
the results to the most objective and stringent analyses. I hope this acquired trait has been 
passed on to my daughter. 
I am grateful for all the discussion, scientific and non-scientific, that I had with Paul D. 
Gardner and Andrew R. Tapper. They introduced me to the magical field of 
neuroscience, which is astonishing to me every day anew. Paul has instilled in me an 
understanding of how great science can be, when it is taught right. I will always 
remember the laughs we had. Shackleton’s map hangs right in front of me, while I am 
writing this. 
 
Shweta, you made the experiments so much more fun, when you joined Ollie’s lab in 
2016. Your friendship means a lot to me. 
 
I would like to thank Jennifer, David, and Rubing, who all contributed to the publication 
of the manuscript. 
 
Carol and Josephine, you had to be so patient with me during all these years, especially 
during the last stretch of writing. Your love has been a permanent encouragement to me. 
All of this would not have any value without the two of you. I love you. 
	 vi	
Abstract 
 
Environmental conditions imposed onto organisms during certain phases of their life 
cycles such as embryogenesis or puberty can not only impact the organisms’ own health, 
but also affect subsequent generations. The underlying mechanisms causing 
intergenerational phenotypes are not encoded in the genome, but the result of reversible 
epigenetic modifications. This work investigates in a mouse model the impact of paternal 
nicotine exposure on the next generation regarding addictive behavior modulation, 
metabolic changes, and molecular mechanisms. It provides evidence that male offspring 
from nicotine-exposed fathers (NIC offspring) are more resistant to lethal doses of 
nicotine. This phenotype is sex-specific and depends on short-term environmental 
challenges with low doses of nicotine prior to the LD50 application. The observed 
survival phenotype is not restricted to nicotine as drug of abuse, but also presents itself, 
when NIC offspring are challenged with a cocaine LD50 after acclimatization to low 
doses of either nicotine or cocaine. Functionally, NIC offspring metabolize nicotine faster 
than controls. Mechanistically, NIC offspring livers show global up-regulation of 
xenobiotic processing genes (XPG), an effect that is even more pronounced in primary 
hepatocyte cultures. Being known targets of Constitutive Androstane Receptor (CAR) 
and Pregnane X Receptor (PXR), these XPGs show higher baseline expression in naïve 
NIC offspring livers. Nicotine’s action on the brain’s reward circuitry does not appear to 
be of biological significance in our model system. Taken together, paternal nicotine 
exposure leads to an non-specific and conditional phenotype in male NIC offspring that 
may provide a general survival advantage against xenobiotic challenges. 
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C H A P T E R  I : I N T R O D U C T I O N 
 
Smoking and Nicotine Addiction as Major Health Issues 
 
Smoking has been a leading cause of cancer and ultimately death worldwide. Indeed, 
more than 480,000 people die in the United States each year as a result of smoking. It is 
estimated that more than 10% of these deaths are related to second-hand smoke exposure 
(CDC, 2014). Although the current opioid addiction crisis is much more present in the 
news and academic discourse, nicotine as the addictive component of tobacco poses a far 
greater risk to the general population for three major reasons:  
1) Smoking causes or is associated with a variety of detrimental diseases such as cancers 
of the lung, larynx, esophagus, and even liver and colorectal cancer, or chronic diseases 
such as stroke, aortic aneurysm, coronary heart disease, Chronic Obstructive Pulmonary 
Disease (COPD), asthma, and male erectile dysfunction and infertility in both genders 
(CDC, 2014). 
2) More people are addicted to smoking than to opioids and the age range is much wider 
than for other drugs of abuse (CDC, 2014). According to the American Society of 
Addiction Medicine (ASAM), the United States saw 52,404 lethal drug overdoses in 
2015 with 20,101 of these deaths related to prescription pain medicine and 12,990 of 
these being heroin overdoses (CDC, 2015). This is an astonishing number and requires 
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the full attention of the medical community, but evanesces in the light of the death toll 
that is caused by smoking and nicotine addiction. 
3) As many nicotine addicts display a relatively normal family life and enjoy greater 
social acceptance of their habits - to at least some extent - than opioid addicts, the risk of 
negatively influencing their social environment is much higher than with other drugs of 
abuse, which are generally seen as already dangerous and undesirable by society, 
especially when they are associated with intravenous application methods as in the case 
of heroin. The advent of electronic cigarettes has made this trend more pronounced in so 
far that inhaling nicotine vapor is less restricted and even more accepted than smoking 
cigarettes. The medical and public health community has yet to respond to this new 
nicotine application format.   
It is, therefore, of pivotal importance to bring smoking, nicotine use, and nicotine 
addiction back into the focus of the public eye. 
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Mechanisms of Action of Nicotine 
 
As stated above, tobacco use kills up to half of its users during their lifetime, resulting in 
a total worldwide death toll of nearly six million people per year (including ~600,000 
non-smokers exposed to second-hand smoke) ((WHO), 2010; Cena et al., 2011; 
Changeux, 2010; Dome et al., 2010; Hurt et al., 2011; Prasad et al., 2009). If this negative 
trend continues, smoking will kill approximately 10 million people per year by 2020 
(CDC, 2014). The addictive component of tobacco, nicotine, acts by stimulating nicotinic 
acetylcholine receptors (nAChRs), which are present not only in the CNS, but also in 
peripheral tissues such as muscle, lung, gastrointestinal tract, and testes (Dani and 
Bertrand, 2007; Gotti and Clementi, 2004; Grando et al., 2003; Kummer et al., 2006; Lips 
et al., 2007; Palmero et al., 1999; Schirmer et al., 2011; Wessler and Kirkpatrick, 2008). 
Nicotine binds these receptors as an agonist competing with endogenous acetylcholine, 
thus changing the protein and mRNA expression levels of nAChRs. In contrast to other 
competitive ligands, nicotine does not result in down-regulation of its receptor, but 
instead chronic nicotine exposure causes an up-regulation of nAChRs, which can be 
explained by desensitization of the receptor that is preceded by receptor activation 
(Fenster et al., 1999; Perry et al., 1999).  
Nicotine causes the typical symptoms of reinforcement, tolerance, and dependence by 
acting within the mesostriatal and mesocorticolimbic dopamine (DA) pathways in the 
brain (D'Souza and Markou, 2011; Dani and Bertrand, 2007). Nicotine also activates 
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dopaminergic (DAergic) neurons in the ventral tegmental area (VTA), leading to DA 
release in the Nucleus Accumbens (NAc) and the prefrontal cortex (PFC). The 
mesocorticolimbic DA pathways, especially the electrochemical relays in the VTA and 
the NAc, contain a variety of nAChR subtypes that can be detected on a transcriptional 
level. These nAChR subunits are α3, α4, α5, α6, β2, and β3, all of which show high-
affinity nicotine binding when incorporated into the cell membrane as a pentameric ion 
channel receptor (Azam et al., 2002). In addition, high density cell membrane levels of 
α4 and β2 subunits have been shown on the protein level in DAergic neurons of the VTA, 
which play a particularly prominent role in the behavioral and rewarding effects of 
nicotine (Nashmi et al., 2003; Tapper et al., 2004). Nicotine’s stimulation of the 
endogenous reward system through DA release causes positive feelings during smoking 
and reinforces addictive behavior. Conversely, nicotine withdrawal results in multiple 
negative symptoms consisting of both a somatic/physical component cued by the CNS 
and the peripheral nervous system (PNS), as well as an affective component, which might 
be due to the overstimulation of DAergic neurons in the reward circuitry during nicotine 
exposure and a corresponding desensitization of nAChRs that prevents physiologic DA 
release, when the exogenous stimulus has disappeared (Watkins et al., 2000). 
Additionally, the aversive effects of nicotine withdrawal are caused by Corticotropin-
releasing factor (CRF) synthesis in DA-ergic neurons VTA that is released into the 
Interpeduncular Nucleus (IPN) (Grieder et al., 2014; Zhao-Shea et al., 2015). 
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Figure 1.1: 
 
Figure 1.1. Action of nicotine on nAChRs within the reward circuitry of the brain. 
Most neurons in the VTA are DA-ergic and receive excitatory stimuli from cholinergic 
neurons of the Laterodorsal Tegmental Nucleus (LDTg) and the Pedunculopontine 
Nucleus (PPTg). DA-ergic neurons of the VTA can also be stimulated by glutamatergic 
(Glu-ergic) neurons originating in different areas of the brain including the prefrontal 
cortex. Inhibitory signals are mainly mediated by γ-aminobutyric acid-ergic (GABA-
ergic) neurons within the VTA itself. DA-ergic neurons of the VTA project to neurons 
within the NAc and receive regulatory stimuli from cholinergic neurons in the NAc. 
Nicotine can bind to various subtypes of pentameric nAChRs consisting of different α 
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and β subunits in these areas of the brain and stimulate dopamine release. Picture and 
legend adapted from (Changeux, 2010).  
 
Addictive behavior, in general, is strongly correlated with social interactions, educational 
and economic status of the addict, and other socio-psychological trajectories. For 
example, the higher the educational status of an individual, the less likely is this 
individual to be a smoker (CDC, 2014). The transition from experimental smoker to 
regular smoker can be fluid and happens very quickly. The CDC states in its report that 
as few as 100 cigarettes can already push a person into the addictive realm. If a person 
starts smoking during the adolescence phase, this transition may happen faster (CDC, 
2014). The adolescence phase is also a period, in which areas of higher cognitive function 
such as the prefrontal cortex, but also the amygdala and the limbic system, display 
increased developmental activity such as neuronal remodeling and synaptic pruning 
(Gogtay et al., 2004). This is true for the general acetylcholine system of these brain 
regions (Poorthuis et al., 2013), so the onset of addictive nicotine behavior during this 
developmentally vulnerable time in a person’s life makes nicotine’s interference all the 
more detrimental (Goriounova and Mansvelder, 2012). It is, however, also true that not 
everybody, who experiments with cigarettes during adolescence or any other time for that 
matter, becomes addicted to nicotine. Twin studies indicate a genetic component to 
nicotine-related behaviors such as smoking persistence, smoking quantity, and nicotine 
dependence (Carmelli et al., 1992; Heath and Martin, 1993; Li et al., 2003; True et al., 
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1997). Furthermore, genetic variants influence the expression of nAChR subunits such as 
α3, α5, α6, β3 and β4, which are associated with the amount of nicotine consumed in a 
given period of time, the intensity of a person’s dependence on nicotine, as well as with 
diseases such as lung cancer, atherosclerosis and chronic obstructive pulmonary disease 
(COPD) (Berrettini et al., 2008; Bierut et al., 2007; Hurt et al., 2011; Saccone et al., 
2009; Saccone et al., 2007; Thorgeirsson et al., 2008; Winterer et al., 2010). Other 
genetic contributors to nicotine biology include polymorphisms in genes involved in 
hepatic clearance of nicotine, such as the human cytochromes CYP P450 2A6 and 2B6 
(Bloom et al., 2011; Johansson and Ingelman-Sundberg, 2011; Malaiyandi et al., 2005; 
Mwenifumbo et al., 2008; Nakajima et al., 2001; Sellers et al., 2003). As these subunits 
metabolize nicotine in humans, a slower or faster metabolic rate caused by 
polymorphisms can change the number of cigarettes smoked during a 24h period in order 
to keep nicotine levels sufficiently high in addicted individuals. However, all known 
genetic influences on nicotine-related behaviors explain only a small fraction of human 
heredity in nicotine usage (Johnson et al., 2010; Li et al., 2003; Maes et al., 2004). While 
cultural inheritance and rare SNPs could account for some of the missing heritability, an 
emerging hypothesis in complex diseases such as nicotine addition is that inheritance of 
epigenetic information could also serve as a contributor. 
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Intergenerational Inheritance of Acquired Traits 
 
The idea that environmental circumstances, in which an individual develops and grows 
up, can not only affect the health of this organism, but can also change the health 
prospects of future generations, a theory famously articulated by French biologist Jean-
Baptiste Lamarck in his, at the time ridiculed, explanation as to why giraffes had evolved 
with such long necks, received renewed attention, when retrospective human cohort 
studies about the so called Dutch-Hunger-Winter were published in 2001 (Roseboom et 
al., 2001) and 2006 (Roseboom et al., 2006). During a certain, short period of time at the 
end of 1944 and beginning of 1945, the Netherlands suffered from severe food shortage 
and extreme famine with daily food portions dropping below 500 kilocalories per person 
at one point. Researchers looked at individuals, whose mothers were pregnant during this 
time of starvation, and found that those people had an increased risk of developing 
metabolic syndrome, glucose intolerance, and cardiovascular diseases 50 and 55 years 
after the occurrence of the event. The effects were more pronounced the earlier their 
mothers were in their pregnancies with the first trimester showing the strongest 
phenotype in the offspring. The scientist also discovered that these phenotypes correlated 
with hypo-methylation of the IGF-2 locus in these individuals (Roseboom et al., 2006; 
Roseboom et al., 2001). It is reasonable to imagine that individuals with IGF-2 hypo-
methylation would utilize resources better in times of food shortage and famine, but have 
a disadvantage in terms of increased energy storage under normal living conditions, 
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which would in turn lead to all the metabolic disorders that were observed in the children 
of the Dutch Hunger Winter.  
Another famous cohort study looked at harvest and food supply records of an isolated 
parish in northern Sweden, Överkalix, and correlated those with survival data and death 
records of the local church (Bygren et al., 2001; Kaati et al., 2002; Pembrey et al., 2006). 
An interesting finding here was that the time point of a certain exposure in one generation 
played a pivotal role in the transmission of epigenetic information to subsequent 
generations. For example, a male person’s food supply before a crucial period of their 
adolescent development, the so called pre-pubertal slow growth period (SGP), usually 
between the ages eight and twelve, was inversely correlated with their grandson’s 
longevity. In a similar manner, a grandmother’s food supply in their early years from 
infancy to early puberty (zero to thirteen years of age), or rather dramatic changes in food 
supply during these years, affected their granddaughters’ mortality and increased their 
risk to develop cardiovascular diseases. In all these analyses of correlations between 
grandparents and grandchildren, researchers observed a gender difference in the sense 
that grandmothers’ exposure affected only granddaughters’ phenotype and grandfathers’ 
exposure affected only grandsons’ phenotype. This gender difference, however, held also 
true when links between fathers and sons in terms of longevity and mortality were studied 
and data were normalized to a son’s early life experiences as potential confounders such 
as whether his parents died, parental literacy status, family size, consanguinity on the 
grandfathers level, and what quantitative rank this son had amongst the total number of 
children, i.e., first born, second born, etc. (Kaati et al., 2007). 
		
10	
One of the major conclusions drawn from the Överkalix study was that the SGP is a 
particularly sensitive period during a human being’s development that can not only affect 
themselves, but contribute to the health phenotype of future generations. To further test 
this hypothesis, the Avon Longitudinal Study of Parents and Children (ALSPAC) was 
designed (Pembrey et al., 2006). Researchers found, that a father’s smoking habits of the 
past, even when adjusted for smoking at conception, are correlated with a son’s, but not 
daughter’s, body-mass-index (BMI) increase at the age of nine, again right during the 
critical SGP. The effects were greatest, when fathers started smoking very early, indeed, 
before the age of 11. The earlier the paternal onset of smoking, the greater the sons’ BMI 
at age nine. At the age of 13 and up, sons from fathers, who started smoking before the 
age of eleven, had an average of five to ten kilogram more fat mass (Northstone et al., 
2014). For our experimental design of paternal nicotine exposure in a mouse model and 
the concomitant hypothesis behind it, it is worth noting, that in the ALSPAC study a very 
specific exposure or stimulus in the paternal generation was associated with a change in a 
very non-specific or general metabolism rate in the F1 generation. 
Since then, a plethora of studies on epigenetic inheritance have been published, so that 
we can now define epigenetic inheritance as the inter- or transgenerational transmission 
of information beyond the DNA sequence, which includes DNA methylation, histone 
modification, small RNA populations, and other entities that can be preserved during the 
fertilization process and have the ability to influence its outcome. The majority of 
examples of intergenerational (two generations involved) and trans-generational (more 
than two generations involved) information transfer in mammals concern maternal 
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influences on offspring (Harris and Seckl, 2011), including in-utero passage of 
photoperiod information in various rodents (Horton, 2005; Varcoe et al., 2011), cultural 
inheritance of stress reactivity, and maternal grooming behavior in rats (Champagne and 
Meaney, 2001; Champagne et al., 2004; Champagne et al., 2003; Fish et al., 2004; 
Meaney et al., 2007; Weaver et al., 2004), as well as metabolic and psychiatric sequelae 
of fetal malnutrition in humans and rodents (Bush and Leathwood, 1975; Hales and 
Barker, 2001; Maekawa et al., 2011; Schulz, 2010; Stein et al., 2004), multigenerational 
effects of treating pregnant females with endocrine disruptors (Alonso-Magdalena et al., 
2011; Gaspari et al., 2011; Guerrero-Bosagna et al., 2010; Guerrero-Bosagna and 
Skinner, 2009; Kang et al., 2011; Masuo and Ishido, 2011; Skinner et al., 2011), and 
altered vitamin intake (Burdge et al., 2009; Smedts et al., 2009; Smedts et al., 2008). 
Since the in-utero environment itself could have effects on the offspring without any 
necessity for transfer of transgenerational information via the germline, multigenerational 
observations have to be performed in order to exclude direct effects of the environment 
on the fetus. For example, if a pregnant women smokes or drinks alcohol during her 
pregnancy, harmful toxins can directly reach the fetus via the placenta as, for example, in 
the so called fetal alcohol syndrome. Other more indirect effects that still have an 
immediate impact on the developing fetus are changes in liver metabolism, increased 
blood pressure of the mother, or stimulation of the intrinsic inflammatory system by, 
once again, alcohol and cigarette smoke (Bakhru and Erlinger, 2005). In the study about 
inflammatory response and smoking, researchers found that it took participants in the 
study 5 years after they had stopped smoking to see their inflammatory biomarkers (C-
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reactive protein or CRP) within normal range again, which is approximately the same 
time period that is required to reduce a smoker’s cardiovascular risk (Dobson et al., 
1991). This fact is of particular interest, since chronic inflammation responses in 
themselves may exert transgenerational transmission potential that could confound 
findings in intergenerational smoking studies even in cases, in which test subjects had 
stopped smoking before conception, depending on the length of time that has passed 
between those two events.  
It is important to note that fathers often provide little more than sperm to their offspring, 
making paternal effects of the environment an ideal approach to studying 
intergenerational inheritance. It has recently been shown that paternal low protein diet 
indeed affects hepatic expression of cholesterol-related genes in offspring (Carone et al., 
2010). These findings were correlated with hypo-methylation of an enhancer sequence 
upstream of Peroxisome Proliferator-Activated Receptor Alpha (PPARα), a Nuclear 
Hormone Receptor (NHR), which is involved in the regulation of lipid metabolism. This 
is consistent with the epidemiological findings of the Överkalix and ALSPAC studies as 
described above. As the paternal generation of mice was exposed to low protein diet, it is 
not too surprising that the offspring phenotype displayed changes in lipid metabolism. 
Both the type of paternal exposure, as well as the response in offspring can be described 
as non-specific interference with general nutrient metabolic pathways in an organism. 
Therefore, we designed a follow-up study of paternal nicotine exposure using a well 
known receptor-ligand interaction to investigate, how specific an intergenerational 
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phenotype could be that responds to an environmental challenge in the paternal 
generation. 
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Specific v. Non-specific Intergenerational Inheritance 
 
There are, generally speaking, two schools of thought on what influence the exposure to 
certain environmental conditions or the change of the same may have on offspring 
phenotype. The vast majority of inter- or transgenerational inheritance studies fall in 
either one of these categories. 
 
Firstly, the offspring response could be non-specific in nature to the parental stimulus. In 
this scenario, subsequent generations would react to a “quality-of-life” event that the 
parental generation experienced in a way that either benefitted the parents or adversely 
affected their overall living conditions. We would, therefore, expect to see a change in 
phenotypes that would make the offspring abler to adapt and adjust to the potential 
recurrence of these parental life events. These phenotypes could include alterations in 
metabolic pathways such as lipid storage, glycolysis, gluconeogenesis, etc. Indeed, most 
inter- and transgenerational studies see changes such as these in offspring. The Dutch 
Hunger Winter analysis described above is a perfect example. The phenotypic outcome in 
first generation children from mothers, who had been exposed to severe famine during 
pregnancy was altered glucose metabolism, metabolic syndrome, diabetes, and 
cardiovascular diseases associated with an up-regulation of IGF-2. An improved 
utilization of nutrients in terms of up-regulation of metabolic pathways would certainly 
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come in handy, when there is shortage of food, but can be detrimental in circumstances, 
when there is plenty of food around.  
On the maternal side of inter- and transgenerational inheritance, this phenomenon, that 
the intrauterine environment plays a crucial role in the development of the fetus and 
shortages in this environment can prepare the offspring for poor living conditions later in 
life by priming metabolic pathways in a more efficient way, was described by David J. P. 
Barker in 1992 and has since become known as the Barker Hypothesis or Thrifty 
Phenotype Hypothesis (Hales and Barker, 1992, 2001). The medical community knows 
well that babies, who are too small for their gestational age (SGA), i.e. below the 10th 
percentile at birth, due to intrauterine growth restrictions (IUGR) can develop metabolic 
syndrome later in life. This phenotype is associated with alterations of growth and 
proliferation pathways of IGF-1 (Wallborn et al., 2010). These findings of altered 
metabolic pathways in offspring as a response to adverse in-utero conditions have been 
replicated multiple times in animal models of protein restriction (20% v 8%) (Fernandez-
Twinn et al., 2005; Ozanne et al., 2003), caloric restriction (Jimenez-Chillaron et al., 
2009), or placental insufficiency (Simmons et al., 2005; Simmons et al., 2001).  
On the father’s side, our very own lab has shown that paternal exposure to low-protein 
diet in a mouse model affects cholesterol and lipid metabolism in F1 offspring (Carone et 
al., 2010). Another rather remarkable study that shall be mentioned here looked at a more 
specific exposure paradigm in fathers by using carbon tetrachloride to induce liver 
damage in male rats rather than a diet-based approach (Zeybel et al., 2012). When the 
offspring was exposed to the same chemical compound again, the researchers noticed that 
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these animals displayed improved hepatic healing in a progressive manner over 
generations to the extent that carbon tetrachloride exposure to the F3 generation did not 
result in any liver cirrhosis at all. These findings were restricted to male offspring only. 
The wound healing phenotype correlated with an up-regulation of PPARγ and down-
regulation of Transforming Growth Factor β1 (TGF-β1), which is known to be pro-
fibrogenic. 
Taken together, all these examples of inter- and transgenerational inheritance in human 
and animal studies point toward a more generalized, less specific offspring response to 
parental exposure paradigms. It shall, however, be noted that these studies only look at 
metabolic pathways. We cannot decide whether this is, because the researchers did 
indeed look at other phenotypes, as well, but did not report on them, as there was no 
difference between groups, or because other phenotypic read-outs such as behavior or 
specific compound responses were not considered in the first place, even in the case of 
the wound-healing study, which again reported a rather non-specific offspring response.  
There are a few exceptions to this, one of them being a study that came out of the 
Mansuy laboratory in Switzerland (Gapp et al., 2014). Here, researchers subjected male 
mice to a daily regimen of maternal separation combined with unpredictable maternal 
stress (MSUS) from postnatal day 1 to postnatal day 14. Offspring were obtained by 
mating either MSUS males or control males with control females. The peculiarity of this 
paradigm is that both metabolic and behavioral responses were tested in MSUS and 
control offspring. MSUS F1 and, remarkably, also F2 male offspring displayed reduced 
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fear and avoidance in the elevated-plus maze and light-dark box experiments. These 
results were combined with an analysis of F1 and F2 blood insulin and glucose levels at 
baseline and post corticosteroid injection to mimic a stress response. MSUS offspring 
displayed insulin hyper-sensitivity and hyper-metabolism, with the latter being present 
only in F2 males. Separation stress and anxiety, on the other hand, are again very non-
specific stimuli that could act on many different receptors in many different organs and 
tissues in the body from liver to brain and anything in between. In human studies, a large 
Japanese human cohort study found that children with SGA displayed behavioral 
abnormalities at the age of eight such as attention problems and aggressive behavior 
towards others (Takeuchi et al., 2017), as well as difficulties in performing independent 
tasks such as walking or using a spoon to eat at the age of two and a half years (Takeuchi 
et al., 2016). 
Thus, although the Mansuy and Japanese cohort studies are rather unique in their read-out 
by using behavioral tests and metabolic analyses, the stimuli applied to the parental 
generation are still general. Therefore, it cannot be concluded from any of these studies 
that epigenetic inheritance of acquired traits follows either a “quality-of-life” paradigm 
beyond what was tested here or could also be more specific depending on the stimulus. 
 
Secondly, the offspring response could be specific in nature to the parental stimulus. The 
number of studies that try to expose parents to a more specific stimulus, i.e., choosing a 
compound that elicits, for example, a specific receptor-ligand response, is astonishingly 
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small. There is, however, one study that stands out (Dias and Ressler, 2014). Here, 
researchers used an adverse odor, acetophenone, to stimulate a specific olfactory 
receptor, Olfr151. The experimental design and flaws of this study will be addressed in 
the discussion section of this work. For now, it suffices to say that the scientists found 
that subsequent mouse generations reacted more sensitively to acetophenone, when their 
fathers had been exposed to this odor as well. This behavioral finding was associated 
with hypo-methylation of Olfr151 in sperm from the paternal and naïve male F1 
generations.  
Besides this particular study, there is not much else known about specific inter- or 
transgenerational interaction studies. In other experiments, researchers exposed the 
parental generation to endocrine disruptors such as Methoxychlor (Murono and Derk, 
2005), the fungicide Vinclozolin (Uzumcu et al., 2004), and Bisphenol-A (Maffini et al., 
2006). These endocrine disruptors are of particular interest, as they have been shown to 
cause sub-fertility in men (Den Hond et al., 2015). Although all these chemical 
compounds can bind to receptors in the body, they can also be non-specific in their 
interactions with metabolizing enzymes such as cytochrome P450. For example, 
Bisphenol-A interferes with estrogen signaling by binding to ERR-γ in a variety of 
tissues, amongst them the placenta with a high level of ERR-γ expression (Takeda et al., 
2009; Tohme et al., 2014), thus affecting sexual differentiation, behavior, and gene 
expression (Ilagan et al., 2017; Kundakovic et al., 2013). In the case of Bisphenol-A, the 
binding partner is clear. In other cases such as Methoxychlor and Vinclozolin, the entities 
involved in binding are less defined or less determined. Glucocorticoid receptors have 
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been implicated in these interactions (Zhang et al., 2016), as have gap junction proteins 
such as connexin-43 and the activation of MAP kinase pathways (Babica et al., 2016). 
The read-out in all these studies is rather metabolism-centric, and does not involve any 
behavioral experiments. 
In summary, without taking the Olfr151 exception into account, even experimental 
paradigms that expose the parental generation to a more specific stimulus cover a wide 
range of receptors and pathways and cannot serve as specific receptor-ligand interaction 
studies. 
 
We, therefore, sought to embark on the adventure to investigate a receptor-ligand 
interaction (nicotine – nAChRs), which is truly specific indeed, and perform extensive 
phenotype characterization of the F1 offspring on both behavioral and metabolic levels. 
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Study Goal and Hypothesis 
 
The goal of this study is to determine whether paternal exposure to a specific 
environmental compound leads to a specific phenotype response in offspring or a more 
generalized change in offspring metabolism.  
 
We hypothesize that paternal nicotine exposure will lead to a phenotype in offspring from 
nicotine-exposed fathers that is  
1) distinctly different from what is seen in control offspring and  
2) nicotine-specific either in terms of tissue or organ preference or in terms of functional 
outcome such as altered behavior. 
 
By using nicotine, we are able to investigate a specific receptor (nAChR) ligand 
(nicotine) interaction that has the potential to elicit an F1 phenotype that is specific to 
nicotine, possibly mediated through the very same receptors. We use a mouse model of 
paternal nicotine exposure, as it allows us to control for confounders such as social and 
environmental interactions, food intake, or sleep-wake cycle more rigorously. The scope 
of this investigation is an extensive analysis of the F1 generation on a phenotypic and, as 
far as possible, on a mechanistic level, not how this information about nicotine exposure 
could potentially be transferred from fathers to offspring. We will describe a variety of 
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behavioral and phenotypic tests that enable us to systematically characterize the 
phenotypic observations that we make in F1 offspring from nicotine-exposed and control 
fathers. We will also propose a potential mechanism that could be responsible for the 
observed phenotype within the F1 generation. We will not investigate nor speculate on 
potential mechanisms that could be responsible for the preservation of this information 
through the paternal germline over generations. We hope that we can, with this study, 
contribute to the understanding of phenotypic responses in offspring as a function of 
intergenerational inheritance. 
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C H A P T E R II :  S T U DY  R E P O R T 
 
Preface 
 
The body of this work is reprinted from the following work: 
Paternal nicotine exposure alters hepatic xenobiotic metabolism in offspring 
Markus P. Vallaster1, Shweta Kukreja1, Xin Y. Bing1, Jennifer Ngolab2,3, Rubing Zhao-
Shea2,3, Paul D. Gardner2,3, Andrew R. Tapper2,3†, and Oliver J. Rando,1† 
1Department of Biochemistry and Molecular Pharmacology, University of Massachusetts 
Medical School, Worcester, MA 01605, USA 
2Brudnick Neuropsychiatric Research Institute, Department of Psychiatry, University of 
Massachusetts Medical School, Worcester, MA 01604, USA 
3Department of Psychiatry, University of Massachusetts Medical School, Worcester, MA 
01604, USA 
Elife. 2017 Feb 14;6. pii: e24771. doi: 10.7554/eLife.24771. 
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Contributions: 
Markus P. Vallaster (MPV) performed behavior experiments and phenotypic profiling in 
mice (Fig. 2.1, 2.3. 2.4, 2.5, 2.6), toxicity study (Fig. 2.7, 2.12, 2.13). Rubing Zhao-Shea 
(RZS) was responsible for the elevated-plus maze study (Fig. 2.2). Cotinine levels post 
nicotine injection were collected, measured, and analyzed by MPV (Fig. 2.9A). Shweta 
Kukreja (SK) executed glucose and insulin tolerance tests, pRT-PCR validation of 
Cyp2a5, Scdf1, and Apoa2, and analyzed the data (Fig. 2.10). Hepatocyte isolation and 
culture were performed by MPV (Fig. 2.9B). MPV and SK collected and processed in-
vivo and in-vitro liver samples for RNAseq (Fig. 2.9C-E). MPV dissected tissue, made 
RNAseq libraries, and analyzed RNAseq data from brain regions (Fig. 2.8A-B). Samples 
for ATACseq (Fig. 2.9F, Fig. 2.11, were collected by MPV and SK, processed by SK, 
and analyzed by Xin Y. Bing (XYB). Tissue dissection of the hippocampus region was 
performed by MPV (Fig. 2.8C-E). Hippocampus was processed for immune-histological 
staining and resulting data were analyzed (Fig. 2.8C-E) by Jennifer Ngolab (JN). Livers 
for immune-histological assessment of apoptosis (Fig. 2.14) were dissected by MPV, 
stained by the Pathology Core Facility of University of Massachusetts Medical School, 
and analyzed by MPV. Paul D. Gardner, Andrew R. Tapper, and Oliver J. Rando 
supervised the project, provided conceptual input, and analyzed the data. The manuscript 
was originally written by MPV and reviewed and and edited by ART and OJR. 
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Abstract 
 
Paternal environmental conditions can influence phenotypes in future generations, but it 
is unclear whether offspring phenotypes represent specific responses to particular aspects 
of the paternal exposure history, or a generic response to paternal “quality of life”. Here, 
we establish a paternal effect model based on nicotine exposure in mice, enabling 
pharmacological interrogation of the specificity of the offspring response. Paternal 
exposure to nicotine prior to reproduction induced a broad protective response to multiple 
xenobiotics in male offspring. This effect manifested as increased survival following 
injection of toxic levels of either nicotine or cocaine, accompanied by hepatic up-
regulation of xenobiotic processing genes, and enhanced drug clearance. Surprisingly, 
this protective effect could also be induced by a nicotinic receptor antagonist, suggesting 
that xenobiotic exposure, rather than nicotinic receptor signaling, is responsible for 
programming offspring drug resistance. Thus, paternal drug exposure induces a 
protective phenotype in offspring by enhancing metabolic tolerance to xenobiotics. 
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Introduction 
 
Environmental conditions experienced in one generation can affect phenotypes that 
manifest in future generations, a phenomenon sometimes referred to as the “inheritance 
of acquired characters.” In mammals, a substantial body of literature links various 
maternal exposures to offspring phenotypes (Harris and Seckl, 2010; Rando and 
Simmons, 2015; Simmons, 2011), and an increasing number of studies have shown that 
paternal environment can also alter offspring phenotype (Rando, 2012). Paternal effect 
paradigms are of particular mechanistic interest in mammals, given that it is challenging 
to disentangle maternal environment effects on the oocyte epigenome from effects on 
uterine provisioning during offspring development. In contrast, in many paternal effect 
paradigms, males contribute little more than sperm to the offspring, simplifying the 
search for the mechanistic underpinnings of paternal effects on children. A large number 
of paternal exposure paradigms have been used to show that a father’s diet can affect 
metabolic phenotypes in the next generation (McPherson et al., 2014; Rando, 2012), 
while another large group of studies link paternal stress (using paradigms such as social 
defeat stress, or early maternal separation) to anxiety-related behaviors and cortisol 
release in offspring (Bale, 2015). Finally, a growing number of toxins and drugs have 
been shown to induce effects on various offspring phenotypes (Skinner et al., 2011; 
Vassoler et al., 2013; Yohn et al., 2015; Zeybel et al., 2012). 
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A key challenge of such studies at present is to understand how the offspring phenotype 
is related to the stimulus presented in the paternal generation – in other words, how 
specific is the offspring response? This challenge is compounded by the fact that many of 
the stimuli used for paternal effect paradigms – low protein and high fat diets, social 
stressors, and endocrine disruptors – have pleiotropic effects on organismal physiology. 
We therefore sought to develop a paternal effect paradigm based on a defined ligand-
receptor interaction, to enable pharmacological interrogation of the specificity of the 
offspring phenotype. Nicotine is a commonly-used drug in humans, and acts by binding 
to and activating nicotinic acetylcholine receptors (nAChRs), ligand-gated cation 
channels normally activated by the endogenous neurotransmitter acetylcholine. Maternal 
use of nicotine has been linked to multiple phenotypes in offspring (Yohn et al., 2015; 
Zhu et al., 2014), and although effects of paternal nicotine exposure have been less-
studied, paternal smoking in humans has been suggested to affect metabolic phenotypes 
in children (Pembrey et al., 2006). 
Here, we develop a rodent model for paternal nicotine effects, asking 1) whether 
exposure of male mice to nicotine could impact phenotypes in offspring, and 2) whether 
any affected phenotype would be specific for nicotine. We found that paternal exposure 
to nicotine induced a protective response in the next generation, as male offspring of 
nicotine-exposed fathers exhibited significant protection from nicotine toxicity. 
Importantly, this toxin resistance was not specific to nicotine, instead reflecting a more 
general xenobiotic response – offspring of nicotine-exposed fathers exhibited increased 
hepatic expression of a variety of genes involved in clearance of xenobiotics, and these 
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animals were resistant to cocaine as well as to nicotine toxicity. Finally, we found that 
enhanced resistance to nicotine toxicity was also observed in offspring of males treated 
with the nicotine antagonist mecamylamine, strongly suggesting that drug resistance in 
offspring is a common outcome of paternal exposure to multiple xenobiotics rather than a 
specific response arising from nicotine signaling. Taken together, our results describe a 
novel paternal effect paradigm, and demonstrate that in the case of paternal nicotine 
exposure, the phenotype observed in offspring is a relatively generic response – enhanced 
xenobiotic resistance – rather than a selective downregulation of the specific molecular 
pathway subject to paternal perturbation. 
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Results 
Effects of paternal exposure history on offspring nicotine sensitivity 
We established a paternal exposure paradigm in which male mice were either provided 
with nicotine hydrogen tartrate (nicotine 200 µg/ml free base, sweetened with saccharine) 
in their drinking water, or a control solution of tartaric acid and saccharine. Mice 
consumed nicotine or control solutions (NIC or TA, respectively) from 3 weeks of age 
until 8 weeks of age. As previously described (Zhao-Shea et al., 2015), this 
administration regimen maintains a high level of nicotine in the bloodstream (Figure 2.1, 
panel A-B), and results in nicotine dependence in exposed animals (Zhao-Shea et al., 
2013). Males were then withdrawn from nicotine for one week prior to mating in order to 
prevent any potential for seminal fluid transmission of nicotine (the half-life of nicotine 
in mice is ~10 minutes, the half-life of its “long-lived” metabolite cotinine is ~40 minutes 
(Siu and Tyndale, 2007)). Nicotine and control males were then mated with control 
females. Overall, we observed no difference in average size or sex ratio of litters arising 
from control or nicotine matings, or in offspring body weights (Figure 2.1, panel C-F). 
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Figure 2.1: 
 
Figure 2.1. Physiological effects of nicotine exposure on treated males. 
(A) Weight of males subject to 5 weeks of exposure to nicotine (NIC) or control (TA) 
solution. Data are shown for animals at the end of 5 weeks of nicotine exposure (** 
indicates p <0.01), and following a week of withdrawal (n.s.: not significant), as 
indicated. 
(B) Blood levels of cotinine, a relatively long-lived metabolite of nicotine, in males (at 8 
weeks of age, following 5 weeks of nicotine/control treatment) consuming control or 
nicotine solutions. 
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(C) Average litter size for offspring of control and nicotine-treated males. Sample size 
reported as number of litters. Data show average plus/minus S.E.M. 
(D) Average gender ratio for offspring of control and nicotine-treated males. Sample size 
reported as number of litters. Data show average plus/minus S.E.M.  
(E-F) Average weights for male (E) and female (F) TA and NIC offspring at 4, 5, and 6 
weeks of age. Data are shown as average plus/minus S.D. 
 
We first sought to determine whether the enforced nicotine withdrawal in our exposure 
paradigm might result in a paternal stress response that could affect the phenotype of 
progeny. As anxiety-related behaviors have been reported in offspring of males subject to 
several distinct stress paradigms (Dietz et al., 2011; Gapp et al., 2014; Short et al., 2016) 
(albeit not all such paradigms – (Rodgers et al., 2013)), we therefore assessed anxiety 
behaviors in TA and NIC offspring. Importantly, we observed no differences between TA 
and NIC offspring in time spent in the center during an open field anxiety test, or in time 
spent or number of entries into the open arms of an elevated plus maze (Figure 2.2). 
These results and results discussed below (see Figure 2.13) indicate that our nicotine 
administration paradigm does not induce a stress response robustly enough, or for long 
enough prior to mating, to affect offspring phenotype. 
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Figure 2.2: 
 
Figure 2.2. Paternal nicotine exposure does not affect offspring anxiety-related 
behaviors. 
(A-B) Data are shown for elevated plus maze performance – time spent in open arms (A), 
or total entries into the open arms (B) – for TA offspring (n=7) and NIC offspring (n=11). 
(C-J) Open field test performance, shown for the first 10 minutes (C-F) or first 5 minutes 
(G-J) following introduction of the animal into the enclosure. Panels show total distance 
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moved (C,G), velocity (D,H), fraction of time spent in the center of the open field 
enclosure (E,I), and cumulative time spent in the central zone (F,J). 
All data show average +/- S.E.M. None of the differences between TA and NIC offspring 
are statistically significant. 
 
We next asked whether paternal nicotine administration could more specifically affect 
nicotine-related phenotypes in the next generation. We first focused on a physiological 
readout of offspring sensitivity to nicotine, using a well-established assay for suppression 
of locomotor activity by acute nicotine administration (Tapper et al., 2004). Briefly, after 
acclimating animals to a saline injection protocol for three days, animals are injected with 
either nicotine (1.5 mg/kg) or saline, and immediately introduced to a novel environment. 
Saline-injected animals actively explore the novel environment, and locomotor activity is 
quantified over a 40-minute time course (Figure 2.3 – Baseline). In this paradigm, 
injection of nicotine results in rapid suppression of locomotor activity, followed by a 
gradual recovery of exploratory behavior over the time course of the assay. Using this 
assay, we observed no significant difference in nicotine sensitivity between TA and NIC 
offspring, either for male or female offspring (Figure 2.3, Figure 2.4). We therefore 
conclude that the acute locomotor suppression response to nicotine is not altered by our 
paternal nicotine exposure paradigm. 
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Figure 2.3: 
 
Figure 2.3. Nicotine suppression of locomotor activity is unaffected by paternal 
nicotine history. 
Nicotine effects on locomotor activity were assayed in male offspring of control (TA) or 
nicotine-exposed (NIC) fathers. Data for females and alternative administration regimens 
are shown in Figure 2.4. For each plot, males were injected with either saline or nicotine 
immediately prior to being placed in a novel environment for 40 minutes, during which 
locomotor activity was assessed by the number of times the animal interrupted a light 
beam during each minute. Each time point shows the number of beam crossings in that 
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minute, shown as average plus/minus S.E.M. for all animals tested. Importantly, here and 
throughout the manuscript, the listed number of animals represent the number of litters 
analyzed, as we only assess one animal per litter in a given assay. Data are shown for 
saline injection (“Baseline”) – exploratory behavior decreases over time in saline-injected 
animals as they habituate to the locomotor cage – and for 1.5 mg/kg nicotine injection in 
animals naïve to nicotine (Day 1) or following five or eight prior days of the same 
nicotine injection and locomotor assessment protocol. 
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Figure 2.4: 
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Figure 2.4. No significant effects of paternal nicotine exposure on offspring 
locomotor response to nicotine. 
For each column, offspring of control and nicotine-treated males (TA and NIC, 
respectively) were subject to a locomotor activity assay as follows. Animals were first 
acclimated to intraperitoneal saline injections once a day for three days. On day three 
(Baseline), offspring were injected with saline, then placed in a novel environment – a 
box equipped with infrared photodiodes to enable detection of locomotor activity. Saline-
injected animals actively explore the novel environment, and locomotor activity is 
quantitated over a 40- or 90-minute time course by the number of times the animal 
interrupts the light beam. Exploratory behavior decreases over time in saline-injected 
animals as they fully explore the enclosure. On nine subsequent days (data for four 
representative days are shown in each column), animals are injected with nicotine (1.5 or 
2.0 mg/kg, as indicated) and immediately introduced to the measurement box. In this 
paradigm, injection of nicotine results in rapid suppression of locomotor activity, 
followed by a gradual recovery of exploratory behavior over the time course of the assay. 
Data here are shown as mean plus/minus S.E.M. 
 
We next sought to identify any effects of paternal nicotine exposure on nicotine 
reinforcement in offspring using an operant self-administration assay (Fowler et al., 
2011). Here, after surgical implantation of a catheter into the superior vena cava, animals 
are subject to caloric restriction and trained to nose-poke an active portal to self-
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administer (SA) sucrose. TA and NIC offspring exhibited similar behavior during the 
training period, with the exception of a modest albeit significant difference in sucrose SA 
on the final day of dietary training (Figure 2.5).  
Figure 2.5: 
 
Figure 2.5. Modest effect of paternal nicotine exposure on dietary training. 
Following surgical implantation of a central line, TA and NIC offspring were allowed to 
recover for 3 days. Animals were then subject to caloric restriction (80% of daily diet 
w/w compared to animals feeding ad libitum), placed in a self-administration box with 
two buttons, one of which was marked with a small light. Animals were then provided 
with sucrose pellets in response to a nose poke on the lit button – for 3 days a pellet was 
provided following each correct nose poke, then for one more day two nose pokes were 
required for a pellet, and finally five nose pokes were required for a food pellet for 3 
days. Bars here show the number of food pellets earned in one hour for TA and NIC 
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offspring – NIC offspring earned moderately more sucrose pellets in the final reward 
regime than TA offspring (p=0.03). This enhanced food training carried over to the first 
day of nicotine self-administration (Figure 2.6A), when NIC animals self-administered 
slightly more nicotine than TA animals, but this difference only persisted for the first day. 
 
After seven days of food shaping, animals were placed in the operant chamber, a nicotine 
infusion pump was connected to the central catheter, and the dietary reward for nose-
poking the active portal was replaced with a nicotine infusion. The amount of nicotine 
self-administered every day was then measured per session over the course of 35 days, 
with the nicotine infusion dose increasing every 4-8 days (Methods). Overall, there was 
no difference in daily nicotine SA between offspring of control males and offspring of 
nicotine-exposed males (Figure 2.6A), indicating that nicotine reward behavior is not 
significantly reprogrammed by our paternal exposure paradigm. 
 
Offspring of nicotine-treated males exhibit enhanced resistance to nicotine toxicity 
Nonetheless, a clear phenotype emerged serendipitously from the SA paradigm. We 
found that in our strain background, the escalating nicotine dosing schedule of SA 
resulted in death of nearly all animals tested at the highest doses used. Surprisingly, NIC 
offspring survived for many more days, on average, than TA offspring (Figure 2.6B). 
This difference in survival was highly significant (Gehan-Breslow-Wilcoxon p < 0.0001). 
As there was no difference in the daily levels of nicotine administered by either group 
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(Figure 2.6A), this result suggests that paternal nicotine exposure can protect offspring 
from nicotine toxicity. 
Figure 2.6: 
 
Figure 2.6. Paternal experience affects nicotine toxicity, but not self-administration, 
in offspring. 
(A) Paternal nicotine exposure does not affect nicotine self-administration in offspring. 
Each day, a mouse trained to self-administer nicotine (Methods) was connected to the 
self-administration apparatus for one hour, with the dose of nicotine administered via 
cannula for every correct nose poke ramping up every 4-8 days, as indicated. Total 
nicotine self-administered is shown for each day of the protocol as average and S.E.M. 
Note that the numbers of animals participating in the trial decreased over time due to 
removal from the protocol (clogged catheter) or death – the listed n represents all animals 
that remained on the protocol until death.  
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(B) Offspring of nicotine-exposed fathers exhibit significant protection from nicotine 
toxicity. Survival curve is shown for all animals on the self-administration protocol 
(underlying data are provided in accompanying Source Data file). Nicotine offspring 
exhibited significantly increased survival during the time course of the assay relative to 
control offspring (Kaplan-Meyer survival curve, P < 0.0001 for both Log-rank test and 
Gehan-Breslow-Wilcoxon test). 
 
As TA and NIC offspring exhibit differences in their resistance to lethal doses of nicotine 
despite no difference in the daily level of nicotine consumed, we asked whether the effect 
of paternal nicotine exposure on offspring survival could be recapitulated using a single 
dose nicotine challenge, rather than the laborious self-administration protocol described 
above. This nicotine challenge was performed using two distinct paradigms. First, we 
simply challenged offspring of control or nicotine fathers with a single dose injection of 
nicotine – these “naïve” animals had had no prior direct exposure to nicotine. In addition, 
we reasoned that since the animals in the self-administration paradigm were consuming 
nicotine for several weeks prior to eventual exposure to lethal levels of the drug (Figure 
2.6B), this would be expected to substantially alter nicotine-related biology in the tested 
animal. We therefore also subjected TA and NIC offspring to one week of chronic low-
dose nicotine (supplied in the drinking water) – we refer to these animals as the “chronic” 
cohort – then challenged these animals with an injection of a single LD50 dose of 
nicotine. 
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As shown in Figure 2.7A, naïve TA and NIC offspring exhibited no significant 
difference in susceptibility to a toxic nicotine injection, indicating that paternal nicotine 
exposure does not program a constitutively nicotine-resistant state. In contrast, and 
consistent with the results of the self-administration test, male (but not female) offspring 
of nicotine-exposed fathers became significantly more tolerant to a lethal nicotine 
challenge than control offspring (Figure 2.7B), but only once they had become 
acclimated to a week of chronic nicotine. Taken together, these data demonstrate that 
male offspring of nicotine-exposed fathers exhibit an enhanced ability to develop 
tolerance to toxic doses of nicotine, but that this tolerance is only revealed following 
prior exposure to sub-lethal levels of nicotine. 
Figure 2.7: 
 
Figure 2.7. Paternally-induced protection from nicotine toxicity is primed by 
nicotine exposure in offspring. 
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(A) Survival of TA or NIC offspring following a single injection of nicotine at the 
indicated dose. Above each bar, fraction shows the number of surviving animals over 
number of animals injected. For all four doses tested, there was no significant difference 
in toxicity between TA and NIC offspring (p>0.7 across all 4 doses for males, p>0.8 for 
females). 
(B) Survival of TA and NIC offspring following a single injection of nicotine at roughly 
the LD50 for naïve animals in (A) – 7.2 mg/kg for male offspring, shown in the top panel, 
5.04 mg/kg for females, shown in the bottom panel. Here, offspring were acclimated to 
chronic nicotine in their drinking water for 6 days, with nicotine challenge being 
administered 24 hours following the last day of nicotine consumption. 
 
Paternal nicotine exposure affects xenobiotic clearance in offspring 
What is the physiological basis for the enhanced resistance to nicotine toxicity observed 
in NIC offspring relative to TA offspring? Lethal doses of nicotine induce seizures 
originating in the hippocampus (Fonck et al., 2003). Resistance to such seizures could 
result from highly specific resistance mechanisms such as downregulation of nicotinic 
acetylcholine receptors in the hippocampus, or from relatively nonspecific resistance 
mechanisms such as enhanced detoxification of xenobiotics in the liver. Although we 
cannot definitively rule out a neural basis for the enhanced nicotine resistance observed 
in NIC offspring, several lines of evidence – including extensive RNA-Seq analysis of 
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isolated hippocampus – argue against this resistance resulting from altered neural 
physiology (Figure 2.8, File 2.1). 
Figure 2.8:  
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Figure 2.8. Paternal nicotine has no significant effects on offspring hippocampal 
gene regulation or neural activity. 
(A-B) RNA-Seq of isolated hippocampus from TA and NIC offspring. Scatterplots show 
average mRNA abundance (minimum tpm of 10), with x axis showing average for TA 
offspring and y axis showing average for NIC offspring. (A) shows data for TA and NIC 
animals that had not experienced nicotine (“naïve”), (B) shows data for animals provided 
with chronic nicotine for 6 days. There are no significant effects of paternal nicotine 
exposure on any mRNAs in either condition. Similar results were obtained in preliminary 
studies of the ventral tegmental area, nucleus accumbens, and prefrontal cortex (not 
shown). Importantly, while recent reports document an increase in Igf2 mRNA 
abundance in the hippocampus of 8 week old male offspring of stressed fathers (Short et 
al., 2016), we observed no significant change in Igf2 levels in NIC offspring (see File 
2.1), providing another argument against the hypothesis that our paternal nicotine 
exposure paradigm affects offspring via a paternal stress response. 
(C-D) Paternal nicotine treatment does not affect offspring neural activity in the 
hippocampus. Representative images showing c-fos staining as a proxy for neural activity 
in hippocampus isolated from TA (C) and NIC (D) offspring. Here, animals were put on 
chronic nicotine (200 ug/ml nicotine free-base) for six days. After 24 hr without nicotine, 
animals were injected with 1.5 mg/kg nicotine free-base. Tissue was collected 90 min 
after the injection. 
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(E) Quantitation of c-fos staining data. Y axis shows number of c-fos-positive neurons in 
the gyrus dentatus for nicotine-injected TA (n=12), and NIC (n=13) offspring. 
 
Several lines of evidence thus argue against the drug resistance of NIC offspring resulting 
from altered neural physiology. First, the fact that drug-acclimated animals exhibit 
enhanced resistance to both nicotine and cocaine toxicity (Figures 2.7, 2.12) rules out 
mechanisms involving downregulation or desensitization of either nicotinic acetylcholine 
receptors or the dopamine receptor. Second, RNA-Seq analysis of several brain regions – 
hippocampus, ventral tegmental area, nucleus accumbens, and prefrontal cortex -- 
revealed minimal effects of paternal nicotine exposure on the transcriptome. Finally, we 
found no significant differences in staining patterns of the activity marker c-fos in the 
hippocampus of TA and NIC offspring (Figure 2.8C-E). Thus, while we cannot 
definitively rule out a neural basis for the phenotypes observed in NIC offspring, we 
found no evidence to support such a hypothesis. 
 
In contrast to the lack of relevant molecular changes observed in the brains of NIC 
offspring, we discovered a significant effect of paternal nicotine exposure on hepatic 
detoxification of nicotine in offspring. As shown in Figure 2.9A, nicotine-acclimated 
NIC offspring exhibit significantly higher levels of the long-lived nicotine metabolite 
cotinine at earlier time points after nicotine injection than do TA offspring. This finding 
is consistent with enhanced nicotine clearance underlying the nicotine resistance 
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phenotype displayed by these animals, suggesting that paternal nicotine exposure 
programs a state of enhanced metabolic tolerance in offspring. 
Figure 2.9: 
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Figure 2.9. Paternal nicotine exposure induces an exaggerated protective response to 
xenobiotics. 
(A) Paternal nicotine exposure enhances nicotine metabolism in offspring. Male TA and 
NIC offspring were acclimated to nicotine for 6 days, then 24 hours later were injected 
with 1.5 mg/kg nicotine. Serum levels of the long-lived nicotine metabolite cotinine were 
measured at the indicated times after nicotine injection, with significantly (p<0.0002, t-
test with Holm-Sidak correction) elevated cotinine levels being observed at the earliest 
time point analyzed, indicating enhanced nicotine clearance in NIC offspring. 
(B) Schematic of hepatocyte RNA-Seq experiment. 
(C) Cluster of hepatocyte RNA-Seq dataset. For each paternal treatment group (TA or 
NIC), data are shown for ten individual male offspring from ten separate litters, with 
hepatocytes from five animals also being cultured for varying times (0 to 21 hours) 
following isolation. Data are z score normalized for each culture time point. The heatmap 
shows 60 genes (filtered for average expression >25 ppm) changing with a multiple 
hypothesis-corrected p value < 0.1. Underlying data are provided in accompanying 
Source Data file. 
(D) Genes upregulated in NIC offspring encode enzymes involved in all three phases of 
xenobiotic metabolism, as indicated. 
(E) Selected Gene Ontology categories enriched among genes upregulated (adjusted p < 
0.1) in NIC hepatocytes. 
		
48	
(F) ATAC-Seq coverage for TA and NIC hepatocytes, as indicated, across Nr1i3. See 
also Figure 2.11. 
 
What is the molecular basis for the enhanced nicotine detoxification observed in NIC 
offspring? As the liver is the primary site of nicotine and other xenobiotic clearance in 
mammals, we investigated changes in mRNA abundance in hepatocytes isolated from TA 
and NIC offspring (Figure 2.9B-C, File 2.2). Paternal nicotine exposure significantly 
(adjusted p < 0.05) affected the expression levels of 51 genes, with upregulated genes 
being significantly enriched for those involved in lipid metabolism (p=3.9e-14), amino 
acid catabolism (p=6.6e-8), and various mitochondrial annotations including 
mitochondrial membrane (p=1.9e-7) (Figure 2.9D-E, Figure 2.10A-B). Most notably, 
given the nicotine resistance observed at the organismal level, NIC hepatocytes also 
exhibited increased expression of genes involved in drug metabolism (p=4.3e-6), with 
upregulated genes including “Phase I” (Cyp1a2, Cyp2c68) and “Phase II” (Ugt2a3, 
Ugt2b1, Sult1d1, and Sult1a1) detoxification enzymes, “Phase III” membrane 
transporters (Slco1a4), as well as genes encoding the xenobiotic-responsive nuclear 
hormone receptors CAR and PXR (Nr1h3 and Nr1i2) (Figure 2.9C-D). In addition, the 
primary cytochrome involved in nicotine clearance in rodents, Cyp2a5, was upregulated 
~2-fold on average in NIC hepatocytes. Although this up-regulation was not significant 
(adjusted p=0.2) in the genome-wide dataset due to sample to sample variability in 
expression of this gene, we validated up-regulation of Cyp2a5 in additional intact livers 
(n=6 NIC, n=4 TA, p<0.01) by q-RT-PCR (Figure 2.10C). 
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Figure 2.10:  
 
Figure 2.10. Paternal nicotine exposure affects multiple phenotypes in offspring. 
(A-B) Glucose tolerance (A) and insulin tolerance (B) are significantly altered in NIC 
offspring relative to TA offspring. Plasma glucose levels are shown for 6 male NIC or 
TA offspring at varying times after a 2 g/kg glucose bolus at 7 weeks of age (A), or a 
0.75 U/kg insulin bolus at 10 weeks of age (B). * and ** represent p values of <0.05 and 
<0.01, respectively (t-test). 
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(C) q-RT-PCR data for the indicated genes. In each case, expression level (after 
normalizing to Actb and Gapdh) is plotted relative to the average expression level for 4 
TA livers (n=6 NIC livers), with bars showing average and S.E.M. 
 
These gene expression studies thus reveal that, relative to TA hepatocytes, NIC 
hepatocytes exhibit a general derepression of target genes for a broad range of nuclear 
hormone receptors. To investigate the mechanistic basis for this derepression, we 
characterized open chromatin genome-wide in TA and NIC hepatocytes (n=8 samples 
each) using ATAC-Seq (Buenrostro et al., 2015). Our ATAC-Seq dataset exhibited 
expected features such as strong peaks of accessibility over promoters and other 
regulatory elements (Figure 2.11). Comparing TA and NIC datasets, we observed a 
consistent global difference in overall chromatin accessibility – normalized ATAC peaks 
at regulatory elements were nearly 2-fold higher in NIC hepatocytes than in TA 
hepatocytes, while TA hepatocytes exhibited a consistently higher background of 
transposition throughout regions of the genome distant from regulatory elements (Figure 
2.11A-C). Whatever the basis for this global change in chromatin accessibility, we 
additionally identified 1861 peaks of chromatin accessibility (Figure 2.9F, Figure 
2.11D-H, File 2.3) that differ significantly between TA and NIC hepatocytes after 
correcting for the global difference in peak height between these samples. Consistent 
with the changes in mRNA abundance observed in hepatocytes, these peaks were 
significantly enriched near genes involved in lipid metabolism (p=2.8e-18) and 
xenobiotic metabolism (p=1.3e-6), along with many related GO categories. We conclude 
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that a history of paternal drug exposure can influence the chromatin landscape of 
hepatocytes in offspring, resulting in a broad increase in accessibility at regulatory 
elements involved in metabolism and detoxification. 
Figure 2.11: 
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Figure 2.11. Global differences in hepatocyte chromatin architecture between TA 
and NIC offspring. 
Aggregated ATAC-Seq data for hepatocytes isolated from TA and NIC offspring (n=4 
animals each, with dexamethasone-treated and -untreated samples for each animal). 
(A) Multimegabase-scale differences in the accessibility landscape of TA and NIC 
hepatocytes. Top two panels show ATAC-Seq data for NIC and TA offspring for 
chromosome 6, along with an averaged NIC-TA score, followed by gene density. For 
chromosome 7, only NIC-TA and gene density are shown. Red boxes highlight a subset 
of genomic regions of low gene density in which TA hepatocytes exhibit greater ATAC-
Seq signal than NIC hepatocytes. Conversely, gene-dense regions generally exhibit 
higher ATAC signal in NIC hepatocytes (not highlighted). The mechanistic basis for this 
global difference is unclear – it does not appear to reflect contamination of TA samples 
with dead cells, for example, as these samples (from nicotine-naïve animals) did not 
differ in viability, and plating of hepatocytes also effectively selects against dead cells. 
As fragment length distributions were consistent from library to library, it also seems 
unlikely that there were gross differences in the concentration or activity of the added 
Transposase Tn5. Nonetheless, while this difference could reflect meaningful biology, 
such as a global difference in heterochromatin condensation, global differences in any 
genome-wide assay should of course be viewed with skepticism. 
(B) ATAC-Seq data for 500 bp surrounding all annotated transcription start sites (TSSs), 
sorted from high to low average ATAC signal intensity. 
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(C) Increased ATAC signal in NIC hepatocytes is shown for all TSSs, or RXRA or 
LXRB binding sites, as indicated. 
(D-H) Examples of loci exhibiting enhanced chromatin accessibility in NIC offspring, 
relative to TA offspring. (D-E) show ATAC-Seq tracks in which TA and NIC data are set 
to the same vertical range, as in Figure 2.9F. For panels F-H, y axes are set 
independently for TA and NIC datasets, visually correcting for the global differences 
between TA and NIC datasets. In these panels, a subset of significantly NIC-enriched 
peaks (File 2.3) are indicated with arrows. 
 
Enhanced xenobiotic resistance in NIC offspring is not specific for nicotine 
Importantly, the gene expression program observed in isolated hepatocytes includes a 
broad variety of genes associated with drug metabolism, most of which are not specific 
for nicotine clearance. To test the hypothesis that the nicotine-resistant state of NIC 
offspring reflects a general xenobiotic response, rather than a nicotine-specific 
detoxification pathway, we asked whether NIC offspring also exhibit enhanced resistance 
to another toxic challenge, cocaine. As cocaine and nicotine operate through distinct 
molecular pathways – cocaine prevents dopamine reuptake at the synaptic cleft by 
binding to and blocking the dopamine transporter, while nicotine activates and 
desensitizes nicotinic acetylcholine receptors – a finding of enhanced tolerance to cocaine 
would strongly argue against NIC offspring exhibiting specific epigenetic effects on the 
direct molecular receptor for nicotine. 
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We first assessed cocaine toxicity in “naïve” animals that had not been previously 
directly exposed to nicotine or cocaine. Similar to our findings with nicotine toxicity 
(Figure 2.7A), naïve NIC and TA animals did not exhibit significant differences in their 
resistance to cocaine toxicity (Figure 2.12A). However, as the enhanced ability of NIC 
offspring to survive toxic nicotine levels was only revealed following pre-exposure of 
these animals to sub-lethal doses of nicotine (Figure 2.7B), we next sought to determine 
whether acclimation of NIC offspring to cocaine could induce a cocaine-resistant state. 
To address this question, TA and NIC offspring were chronically treated with sub-lethal 
doses of cocaine – twice-daily injections of 15 mg/kg cocaine for five days – prior to 
challenge with a toxic dose of cocaine. Astonishingly, this acclimation protocol resulted 
in enhanced resistance to cocaine toxicity in NIC offspring, relative to TA controls 
(Figure 2.12B), revealing that NIC offspring are hyper-responsive to multiple 
xenobiotics. 
 
 
 
 
 
 
 
		
55	
Figure 2.12: 
 
Figure 2.12. NIC offspring are protected from multiple xenobiotics. 
(A) Paternal nicotine exposure does not affect susceptibility of drug-naïve offspring to 
cocaine toxicity. Male TA and NIC offspring were injected with a single 100 mg/kg dose 
of cocaine. Survival is shown as in Figure 2.7. 
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(B) Acclimation of TA and NIC offspring to either nicotine or to cocaine reveals 
protective effect of paternal nicotine exposure on offspring cocaine resistance. As in (A), 
for male offspring acclimated to chronic nicotine (200 µg/mL nicotine free-base in 
drinking water for six days) or cocaine (twice-daily injections with 15 mg/kg cocaine for 
five days). Twenty-four hours following final drug exposure, animals were injected with 
a single 100 mg/kg dose of cocaine. 
(C) Cocaine acclimation induces nicotine resistance in NIC offspring. Here, male TA and 
NIC offspring were acclimated to cocaine injections (twice-daily, 15 mg/kg) over five 
days. Twenty-four hours after the final cocaine injection, animals were injected with 7.2 
mg/kg nicotine. 
 
We next asked whether the process of acclimation to sub-lethal doses of nicotine or 
cocaine induces a drug-specific resistant state in NIC offspring. In other words, does pre-
acclimation of NIC offspring to different molecules induce resistance specifically to the 
drug to which the animals were exposed, or do chronic exposures to multiple distinct 
drugs all induce a common state of general xenobiotic resistance? To distinguish these 
possibilities, we pre-acclimated TA and NIC offspring to either nicotine or cocaine, then 
challenged acclimated animals with a lethal dose of the drug to which they had not yet 
been exposed. Consistent with the hypothesis that drug acclimation induces a general 
xenobiotic response, we found that pre-acclimation to nicotine induced a cocaine-
resistant phenotype in NIC offspring, and, conversely, that chronic cocaine could induce 
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nicotine resistance (Figures 2.12B-C). Together, these data suggest that paternal nicotine 
exposure programs a hyper-responsive state in male offspring in which chronic 
xenobiotic exposure results in a generalized toxin resistance. 
 
Drug resistance is induced by multiple paternal drug exposures. 
The revelation that nicotine resistance in NIC offspring reflects a somewhat generic 
xenobiotic resistance program (Figures 2.9C-D, 12) raises the question of what aspect of 
the paternal nicotine exposure paradigm is responsible for programming the offspring 
phenotype. The nicotine exposure paradigm utilized here induces nicotinic acetylcholine 
receptor (nAChR) signaling, with several physiological consequences: 1) nicotine 
dependence, 2) reduced caloric intake, and 3) physiological withdrawal resulting from the 
removal of nicotine for the final week prior to mating. To investigate the role of nAChR 
signaling in the paternal induction of offspring drug resistance, we made use of 
mecamylamine, a non-selective, non-competitive antagonist of nAChRs that readily 
crosses the blood-brain barrier. 
Male mice were provided with 2.0 mg/kg/day mecamylamine via a surgically-implanted 
infusion pump, and mecamylamine-treated mice were split to either nicotine or TA 
drinking water, as in our primary nicotine exposure paradigm. Studies have previously 
shown that mecamylamine administration prevents known physiological responses to 
nicotine such as nicotine-induced anorexia (Mineur et al., 2011), hypothermia and 
locomotor effects (Tapper et al., 2004), and nicotine reinforcement (Corrigall and Coen, 
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1989). Male offspring of these fathers were then acclimated to nicotine for 6 days, then 
subject to a toxic nicotine challenge, as in Figures 2.7 and 2.12. Surprisingly, male mice 
concurrently treated with nicotine and its antagonist fathered offspring with the same 
enhanced nicotine resistance seen in NIC offspring (Figure 2.6). Importantly, this finding 
rigorously rules out the possibility that our nicotine exposure paradigm induces paternal 
effects on offspring as a consequence of the nicotine withdrawal stress imposed in the 
week before mating.  
Moreover, the drug resistance observed in nicotine + mecamylamine offspring strongly 
argues that this paternal effect does not even require nicotine signaling in treated fathers, 
instead suggesting that the paternal effect is perhaps induced simply by exposure to 
xenobiotics. Consistent with this hypothesis, mecamylamine exposure alone also induced 
drug resistance in the next generation, although this effect was not as robust as that 
induced by nicotine or nicotine + mecamylamine (Figure 2.13). Together, these data 
demonstrate that drug resistance in sons can be induced by paternal exposure to both 
nAChR agonists and nAChR antagonists, arguing that paternal xenobiotic exposure is 
likely to be the relevant feature of our nicotine exposure paradigm. 
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Figure 2.13: 
 
Figure 2.13. Offspring drug resistance is induced by a nicotine antagonist. 
Here, we modified the paternal exposure paradigm by implanting pumps to deliver the 
nicotine antagonist mecamylamine to male mice. Mecamylamine-treated mice were 
provided with nicotine or control solution for four weeks, then mated to control females. 
Male offspring were acclimated to chronic nicotine for six days and then subject to a 
toxic nicotine challenge, and survival is shown as in Figures 2.3, 2.5. Data for no 
mecamylamine animals are reproduced from Figure 2.3B. Note that concurrent 
mecamylamine and nicotine exposure resulted in a protective effect on offspring, and 
even mecamylamine alone was able to modestly induce nicotine resistance in the next 
generation. 
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Relative sparing of hepatocytes following drug treatments in NIC offspring. 
Finally, we sought to understand the requirement for drug acclimation in revealing 
organismal drug resistance in NIC offspring. Curiously, the relative up-regulation of 
xenobiotic processing genes (XPGs) in NIC offspring was observed in hepatocytes and 
livers isolated from “naïve” animals that had not been exposed to nicotine or cocaine 
(Figure 2.9), yet enhanced resistance to toxins was only observed in animals that were 
first acclimated to one of these drugs (Figures 2.7, 2.12). To test the hypothesis that XPG 
up-regulation might be even stronger in NIC hepatocytes following drug exposure, we set 
out to characterize gene expression changes in nicotine- or cocaine-acclimated offspring. 
However, in attempting to isolate hepatocytes from drug-acclimated TA and NIC 
offspring for RNA-Seq analysis, we noticed much poorer recovery of hepatocytes from 
TA than from NIC offspring (not shown), suggesting the possibility that NIC animals 
might be protected from drug-induced hepatotoxicity. Therefore, to quantify cell viability 
in vivo, we took a histochemical approach to assess apoptosis in livers from drug-
acclimated TA and NIC offspring. Consistent with the relatively poor recovery of 
hepatocytes from TA animals, we observed substantial hepatocyte death in the livers of 
cocaine-exposed animals (Figure 2.14A). Importantly, while hepatocyte apoptosis and 
necrosis were extremely common in livers from cocaine-exposed TA offspring, NIC 
offspring were significantly protected from such cocaine toxicity (Figure 2.14). We 
conclude that the up-regulation of XPGs in naïve NIC offspring is not sufficient to 
significantly protect animals from a lethal nicotine or cocaine challenge, but that this up-
regulation can protect hepatocytes from sub-lethal doses of these drugs. Following a 
		
61	
week of chronic toxin exposure, TA offspring are left with substantially reduced liver 
function, while NIC offspring maintain greater numbers of functional hepatocytes. We 
speculate that this greater hepatocyte functional capacity, as well as the up-regulation of 
XPGs in hepatocytes (Figure 2.9), may both serve to protect the animal from a single 
toxic dose of xenobiotic. 
Figure 2.14: 
 
Figure 2.14. NIC offspring exhibit relative sparing of hepatocytes following chronic 
drug exposure. 
(A-B) Effects of chronic cocaine treatment on hepatocyte viability. Two representative 
sections are shown for TUNEL-stained livers from TA (A) and NIC (B) offspring 
following 5 days of cocaine injections (twice-daily, 15 mg/kg). Prominent centrilobular 
apoptosis is seen in TA offspring, but is almost completely absent in NIC offspring. 
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(C-D) Quantitation of TUNEL staining data. (C) shows the average (plus/minus s.e.m.) 
number of TUNEL+ centrilobular regions per slide (staining of >25% of central vein 
circumference was counted as TUNEL+, and was assessed at five different levels for 
each liver lobe I-IV) for 4 individual TA (blue) and NIC (red) offspring, treated as in (A-
B). (D) shows data for all individual slides as dots, with boxplot showing median, 1 
standard deviation, and 5th/95th percentile for the 80 data points. 
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Discussion 
Here, we report a novel paradigm for intergenerational effects of paternal environment on 
offspring phenotype, based on paternal nicotine administration. Our data reveal that 
paternal nicotine exposure programs a state of nicotine resistance in offspring, but, 
surprisingly, neither the paternal sensing machinery nor the offspring response are 
specific for nicotine. 
 
Paternal nicotine exposure induces a pleiotropic, nonspecific set of phenotypes in 
offspring. 
The use of nicotine, a well-characterized small molecule that acts in vivo by binding to 
specific receptors, as the inciting paternal exposure enabled us to rigorously interrogate 
the specificity of the offspring response. Importantly, the enhanced toxin survival seen in 
offspring is not specific for the drug to which fathers were exposed – NIC offspring were 
hyper-resistant to both nicotine and to cocaine challenges – demonstrating that our 
paternal exposure paradigm does not result in transmission of a nicotine-specific 
phenotype to progeny (at least for toxicity, locomotor effects, and reward behavior). 
Mechanistically, the drug resistance observed in NIC offspring presumably results from 
the enhanced hepatic drug clearance observed in these animals (Figure 2.9A). Consistent 
with this increased nicotine clearance, isolated hepatocytes exhibited up-regulation of a 
variety of xenobiotic processing genes (XPGs) accompanied by greater chromatin 
accessibility at relevant regulatory regions. A variety of XPGs are induced in NIC 
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hepatocytes in addition to those known to play a role in nicotine clearance (Figure 2.9C), 
suggesting that NIC offspring may prove resistant to many toxins beyond the two tested 
in this study. 
In addition to the significant de-repression of xenobiotic response genes observed in NIC 
offspring, we note that the most significant effects of paternal nicotine on offspring 
hepatocyte gene expression occurred at metabolic genes (Figure 2.9C, E). This finding 
suggested that NIC offspring might also exhibit metabolic alterations, in addition to the 
documented changes in xenobiotic resistance. Alterations in glucose control and lipid 
metabolism are commonly observed in paternal effect studies, being observed not only in 
dietary paradigms, but also in some stress and toxin-related paternal effect studies (Rando 
and Simmons, 2015), suggesting that multiple distinct stimuli experienced by males 
might in some way convergently influence metabolic traits in offspring. As a detailed 
metabolic phenotyping of NIC offspring is beyond the scope of this study, we chose here 
to simply focus on the most common phenotype observed in other paternal effect 
experiments, assaying glucose and insulin tolerance in TA and NIC offspring (Figure 
2.10). Consistent with the ability of multiple paternal environments to alter glucose 
control in offspring, we observed that NIC offspring exhibited significantly diminished 
clearance of a glucose bolus, as well as a moderately diminished response to insulin. 
Taken together, our data reveal 1) that paternal nicotine exposure induces a pleiotropic 
set of phenotypes in male offspring, and 2) that the induced phenotypes in offspring are 
not specific for nicotine. It will be of great interest in future studies to interrogate a wide 
variety of phenotypes in offspring of males subject to a broad range of exposure 
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paradigms – including stress, nicotine treatment, and various diets – to identify common 
and divergent phenotypes induced by distinct paternal exposure paradigms. 
 
Paternal programming of offspring drug resistance is limited to male offspring. 
A curious feature of many, but not all, paternal effect paradigms reported in mammals is 
that phenotypic effects often manifest preferentially in offspring of one gender. For 
example, while paternal social defeat was reported to affect anxiety-related behavior in 
both male and female offspring, locomotor activity and sucrose preference were only 
altered in male offspring (Dietz et al., 2011). Here, we find that paternal nicotine 
exposure only affects drug resistance in male offspring, raising once again the unsolved 
question of why paternal environments induce gender-specific outcomes in progeny. 
Here, we consider three potential explanations for this phenomenon. 
First, a subset of epigenetic information carriers – cytosine methylation and chromatin 
packaging – are associated in cis with a specific genomic locus, meaning that epigenetic 
changes occurring on the sex chromosomes will only affect progeny inheriting that 
chromosome. Thus, it is plausible that nicotine exposure affects epigenetic modification 
of the Y chromosome to program drug resistance in male offspring (or, less simply, that 
epigenetic marks on the X chromosome suppress an autosomal or small RNA-directed 
phenotype that would otherwise affect both male and female progeny). Second, X 
chromosome dosage compensation in mammals occurs via silencing of one of the two X 
chromosomes in females. The inactive X chromosome could thus act as a “sink” for 
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epigenetic silencing machinery in females (Blewitt et al., 2005), such that the effective 
levels of this machinery available for autosomal gene regulation could differ between 
males and females. In this scenario, paternal transmission of an epigenetically-marked 
autosomal locus, or RNA, could cause differential effects in developing male vs. female 
offspring based on differences in the available levels of epigenetic effector machinery. 
Finally, we note that an emerging theme in many paternal effect paradigms is that the 
phenotypic changes observed in offspring are known to be regulated by various nuclear 
hormone receptors (NHRs). For example, the phenotypes described in paternal stress 
paradigms are related to glucocorticoid receptor signaling, while the metabolic gene 
expression changes resulting from paternal dietary interventions exhibit significant 
overlap with genes regulated by NHRs such as PPARα (Carone et al., 2010). Here, we 
find that paternal nicotine exposure affects hepatic expression of many targets of 
metabolic NHRs, as well as the xenobiotic-responsive NHRs CAR and PXR (Figure 
2.9). As sex hormones also act through NHR signaling – androgen receptor and estrogen 
receptor – we speculate that levels or activity of NHR coactivators or corepressors could 
differ in male vs. female progeny, resulting in altered penetrance or magnitude of 
paternal effects on NHR-mediated gene regulation. 
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Offspring drug resistance is revealed by pre-exposure to xenobiotics. 
A crucial feature of the drug resistance exhibited by NIC offspring is that the toxin-
resistant state is only revealed by pre-exposure of these animals to xenobiotics. This 
requirement for drug pre-exposure/acclimation emphasizes the key role of the offspring’s 
environment in the manifestation of an epigenetically “reprogrammed” phenotype. In 
other words, the development of an animal’s phenotype here involves an interaction 
between environmental conditions in two consecutive generations (see (Rodgers et al., 
2013; Zeybel et al., 2012) for similar examples) – as with gene X environment effects, 
epigenetic marks also have context-dependent effects on organismal phenotype. 
What is the mechanism, by which low level drug exposure enhances the survival of NIC 
offspring? NIC hepatocytes exhibit derepression of xenobiotic response genes even 
before exposure to any drugs, yet these drug-naïve animals are no more resistant to 
nicotine or cocaine toxicity than control animals (Figures 2.7A, 2.12A). Instead, the 
enhanced xenobiotic metabolism in NIC livers appears to protect susceptible hepatocytes 
from toxicity during a course of sub-lethal drug exposure (Figure 2.14). The loss of 
hepatocytes in drug-exposed TA animals presumably explains why fewer than 50% of 
these animals survive an LD50 dose – calculated using drug-naïve animals – of nicotine 
or cocaine (Figures 2.7, 2.12), with the preservation of hepatic capacity in NIC offspring 
preventing this degradation in survivability. That said, not only do drug-acclimated NIC 
offspring simply preserve their survival in the face of an LD50 dose of these drugs, but 
they exhibit dramatically improved survival, as far more than half of these animals 
survive this challenge. We have yet to uncover the mechanistic basis for this enhanced 
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survival, as RNA-Seq analysis of the hepatocytes isolated from drug-acclimated animals 
does not reveal further up-regulation of XPGs than that documented for naïve 
hepatocytes (not shown). Future studies will investigate whether drug acclimation might 
1) affect mRNA abundance in a limited subset of hepatocytes (which would be 
diluted out in whole liver or hepatocyte culture experiments),  
2) affect mRNA abundance only transiently during drug exposure (and not in 
cultured hepatocytes), leaving behind higher levels of the encoded proteins without an 
mRNA-Seq signature, or  
3) affect xenobiotic metabolism not at the level of mRNA abundance, but post-
transcriptionally. 
 
How is nicotine sensed in exposed males? 
The pleiotropic response observed in nicotine-exposed offspring raises the question of 
how nicotine is sensed in the paternal generation in this system. A key question in this 
regard is whether stress experienced by the nicotine-exposed males might be responsible 
for inducing the offspring phenotype, as it is known that a variety of paternal stress 
exposure paradigms – including early maternal separation, social defeat stress, and 
chronic variable low level stress – affect multiple phenotypes in offspring, from glucose 
control to anxiety-related behaviors (Bale, 2015). While we have not formally ruled out a 
role for paternal stress in our system – it will of course be of interest to assay offspring 
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nicotine resistance in well-studied paternal stress paradigms – two findings strongly 
argue against this paternal effect arising from a general stress response. First, chronic 
exposure to the nicotinic receptor antagonist mecamylamine, which blocks nicotine 
dependence in nicotine-treated fathers, does not interfere with induction of xenobiotic 
resistance in offspring (Figure 2.13), thus definitively ruling out a role for paternal 
withdrawal stress in induction of this phenotype. This first point is further supported by 
the finding that mecamylamine alone – which on its own has little effect on anxiety, 
locomotor behavior, or physical withdrawal symptoms in nicotine-naïve mice (Zhao-Shea 
et al., 2013) – is sufficient to induce xenobiotic resistance in offspring. Second, in 
contrast to multiple reported paternal stress paradigms, we do not find any evidence that 
paternal nicotine exposure affects anxiety-related behavior in offspring (Figure 2.2). 
What, then, is the relevant feature of nicotine in inducing xenobiotic resistance in 
offspring? Paternal effects on toxin resistance in offspring did not require nicotinic 
receptor signaling, as both nicotine itself as well as a nicotine antagonist were able to 
induce the protective response in offspring. As both nicotine and mecamylamine 
exposure can result in reduction of nAChR signaling via desensitization or antagonism, 
respectively, it is formally possible that nAChR deactivation is the inciting stimulus in 
the paternal generation (or, less likely, that the surgical stress of mecamylamine infusion 
pump implantation, and nicotine consumption, both convergently induce the same effect 
in offspring). However, we favor the simpler hypothesis that both of these molecules 
serve to program offspring drug resistance via effects on paternal xenobiotic sensing. 
This model naturally raises the question of how xenobiotic exposure is sensed. As a 
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diverse variety of xenobiotics can affect gene regulation via activation of the NHRs CAR 
and PXR, these NHRs represent appealing candidates for the relevant xenobiotic sensor 
in fathers. 
Whatever the nature of the relevant xenobiotic sensor, a key challenge to address is why 
experimental exposure to nicotine or mecamylamine (or, presumably, many other 
xenobiotics) reprograms offspring drug resistance relative to control animals, given that 
control animals are also exposed to a multitude of small molecules even in controlled 
laboratory conditions. Do nicotine and mecamylamine somehow induce a switch-like “all 
or none” change in some epigenetic mark that is not present in control sperm, or is the 
overall activity level of a xenobiotic sensor translated into quantitative changes in the 
levels of some continuous signal present in sperm? In the former case, what aspects of a 
given exposure paradigm are required to induce alterations to the sperm epigenome? We 
offer that one appealing mechanism for sensing increased levels of environmental 
xenobiotics would rely on comparing changes in sensor activity over an animal’s 
lifetime. For instance, if CAR/PXR signaling early in life – in utero perhaps, or early in 
postnatal life – were to result in a long-lasting “setpoint” for the levels of CAR/PXR 
activity expected later in life, then the organism could detect increased xenobiotic 
exposure later in life via changes in overall CAR/PXR activity compared to this setpoint. 
Future studies will explore the nature of the “nicotine” sensor in the paternal generation, 
and how information about exposure history is transmitted to offspring. 
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Taken together, our studies define a novel paternal exposure paradigm based on a specific 
ligand-receptor interaction, and show that paternal nicotine exposure programs offspring 
for enhanced resistance to multiple distinct toxins. Our data also reveal broad metabolic 
gene expression changes in NIC offspring, with potential implications for metabolic and 
cardiovascular health of offspring. Future studies will determine whether paternal 
nicotine exposure affects offspring via epigenetic marks in the sperm (vs. seminal fluid, 
etc.), and how paternally-transmitted information alters the course of development to 
result in xenobiotic-resistant hepatocytes. It will also be of interest to extend these studies 
to human populations, where the longer half-life of nicotine could potentially result in 
self-administration phenotypes not observed in the mouse model. 
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Materials and Methods 
 
Animal husbandry and drug treatments: C57BL/6J mice (RRID:IMSR_JAX:000664), 
3 weeks old, were obtained from Jackson labs on a weekly basis and group-housed (4 
mice/cage) on a 12-hr light-dark cycle (7:00 A.M. to 7:00 P.M). After arrival, males were 
immediately put on either tartaric acid (TA, 375 µg/ml) or nicotine (200 µg/ml nicotine 
free-base) in drinking water for 5 consecutive weeks, followed by an additional week on 
tap water prior to mating. Nicotine-exposed and control males were then allowed to mate 
(for six days) with control females from the same shipment date. F1 offspring from 
nicotine-exposed and control fathers were used for all experiments reported, generally at 
8 weeks of age unless otherwise noted. Animals were maintained on-site in accordance 
with an approved IACUC protocol (A-1788). 
 
Locomotor assay: F1 males from nicotine-exposed and control fathers were pre-
conditioned to handling and injections with 0.9% saline (100 µl, i.p.) for three days prior 
to start of the study. For the nicotine test sessions, animals were injected with nicotine 
and transferred to individual cages placed within an infrared photobeam frame (San 
Diego Instruments). Test sessions lasted 40 or 90 min per day for 9 consecutive days. 
Locomotor activity was defined as the number of beam breaks during a session, 
whereupon the animal had to cross at least 2 photobeams from the original location to 
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count as ambulation. Results were statistically quantified using unpaired t-tests with 
multiple comparison adjustment (Holm-Sidak correction). 
 
Nicotine Self-Administration Assay: Microsurgical catheter implant was performed on 
7-week old F1 males from nicotine-exposed and control fathers. Animals were 
anaesthetized with ketamine (100 mg/kg BW) and xylazine (10 mg/kg BW) followed by 
a intrascapular and right midclavicular incision at the level of the carotid sheath. Blunt 
preparation was used to create a subcutaneous canal between the two incisions. 
Subsequently, the vena jugularis dextra was located and a catheter (2Fr, PV 10 cm, 
Instech Labs) was inserted and gently pushed forward into the vena cava superior, where 
it remained for the length of the study. The catheter was ligated to the vein using 
Ethibond Excel 4.0. The distal end of the catheter was connected to a button (25 G, VAB, 
Instech. Labs), which was placed subcutaneously in an intrascapular position for easy 
access. After verifying that there was no leakage, the incision sites were closed with 
Ethibond Excel 4.0. Through the catheter, the mouse was treated with heparin (15 I.U., 
Sigma-Aldrich) and an antibiotic mix of Ticarcillin (20 mg booster, Sigma-Aldrich) and 
Amikacin (10 mg/kg BW, Sigma-Aldrich). Animals received Ketoprofen (5 mg/kg BW, 
Sigma-Aldrich) once daily during a 3-day recovery phase. Afterwards, mice were put on 
a caloric restriction diet (85% w/w of regular 24-hr consumption) 3 days prior to start of 
the experiment. We preconditioned animals on sucrose pellets in a 60-min session once a 
day for 7 consecutive days, whereby animals learned to nose-poke the active portal in a 
self-administration chamber in order to receive food reward. The number of nose-pokes 
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required to get a sucrose pellet escalated starting with a fixed ratio of 1:1 (FR1) up to a 
fixed ratio of 5:1 (FR5). Only animals that had successfully been conditioned on sucrose 
pellets advanced to the testing phase, during which they administered nicotine to 
themselves through the implanted catheter. Catheter patency was verified daily by 
aspiration of blood and subsequent heparin infusion. Animals with blocked or dislocated 
catheters were excluded from the study. The self-administered nicotine doses started with 
0.03 mg/kg/injection for 4 days, then 0.1 mg/kg/injection for 8 days, 0.25 mg/kg/injection 
for 8 days, and 0.4 mg/kg/injection for 8 days. The number of nose-pokes of the active 
versus the inactive portal, as well as the number of injections administered, were 
recorded and analyzed using GraphPad Prism 7.0 and multiple t-tests with Holm-Sidak 
correction. Survival was plotted as a Kaplan-Meier curve with significance levels 
calculated using modified Chi-square tests (Log-rank and Gehan-Breslow-Wilcoxon).   
 
Cotinine assay: Blood of F1 males from nicotine-exposed or control fathers was 
collected in EDTA-coated tubes after injection of 1.5mg/kg nicotine free-base i.p. at 15 
min, 30 min, and 45 min post-injection. Cellular components were separated from serum 
by centrifugation at 12,000 × g for 10 min. Cotinine levels in serum of chronic F1s were 
measured using a Direct ELISA kit (CalBiotech Inc.). Samples were run as 2 technical 
replicates together with a cotinine standard curve for each 96-well plate. Analysis was 
performed using GraphPad Prism 7. 
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Anxiety assays:  The elevated plus maze consisted of four arms connected by a central 
axis (5 x 5 cm) and was elevated 45 cm above the floor. Two of the arms contained 
plastic black walls (5 x 30 x 15 cm) while the other two remained open (5 x 30 x 0.25 
cm). Mice were individually placed on the center of the maze with their heads facing one 
of the open arms and allowed 5 min of free exploration.  The number of entries into the 
open and closed arms, and the total time spent in the open and closed arms was measured 
by MED-PC IV software (MED associates, Inc.). The apparatus was thoroughly cleaned 
between animals.  For activity in the open field, mice were placed in a rectangular arena 
made of Plexiglas (40 x 40 x 30 cm) and mouse activity was video recorded for 10 min. 
Total activity, velocity, and time spent in the peripheral and central area of the open field 
was analyzed using video tracking software (Noldus Ethovision). 
 
cFos staining and cell count: F1 males from TA- and nicotine-exposed fathers were 
treated as for transcriptome analysis and phenotype studies. Briefly, animals received 
nicotine in their drinking water (200 µg/ml nicotine free-base) for six consecutive days 
starting at seven weeks post-natum. Afterwards, mice were put on filtered tap water from 
12:00 P.M. until 7:00 A.M. the next day followed by immediate tissue collection. Brains 
of additional eight-week old control animals are dissected 90 min after i.p. injection of 
1.5 mg/kg BW nicotine free-base. Animals were anesthetized with sodium pentobarbital 
i.p. (200 mg/kg BW) followed by intracardial infusion of 10 ml ice-cold PBS and 10 ml 
paraformaldehyde (PFA; 4% w/v in PBS). Brains were kept at 4 °C in 4% PFA for 2 hr 
and then transferred into 30% sucrose (w/v in PBS) until slice preparation. 
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Brains were sectioned using a microtome (Leica) into 25-µm slices and immersed in a 
50% glycerol, 50% ethylene glycol solution (Sigma) to preserve the tissue. Brain slices 
were stored in -20 °C until further processing. Using the free-floating immunostaining 
method, slices were washed with PBS for 5 min, permeabilized with 0.5% (v/v) Triton X-
100 (Sigma) for 10 min, and blocked with 3% donkey serum for 30 min. The slices were 
incubated overnight at 4 °C with antibodies against c-Fos (1:1000, catalog number: sc-52, 
lot number: D2315, Santa Cruz Biotechnology, Santa Cruz, CA). After washes with PBS, 
slices were incubated with Alexa Fluor 594 secondary antibodies (1:1000, ref number: 
A21207, lot number: 1602780, Life Technologies, Carlsbad, CA). Counterstaining was 
carried out with DAPI through mounting media (Cat number: H-1200, lot #: ZB0730, 
Vector, Burlington, CA).  Fluorescent images were captured using an AxioCam MRm 
camera (Carl Zeiss, Peabody, MA) attached to a Zeiss Axiovert inverted fluorescent 
microscope equipped with Zeiss filter sets 38HE, 49, and 20. Zeiss objectives A-p were 
subsequently processed using Axiovision version 4.8.2. Quantification of c-Fos-positive 
cells was performed using ImageJ, with a minimum of 6 hippocampal brain slices 
analyzed per animal. 
 
Tissue harvest for hippocampal mRNA-Seq: Seven week-old male F1 animals from 
control (TA) and nicotine-exposed fathers were divided into three treatment groups: 
naïve, chronic, and chronic + stimulation. Naïve mice were not exposed to nicotine 
before tissue collection at 8 weeks of age. Chronic animals received nicotine in their 
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drinking water (200 ug/ml) for six consecutive days. Afterwards, chronic mice were put 
on filtered tap water from 12:00 P.M. until 7:00 A.M. the next day followed by tissue 
collection as for naïve animals. Chronic + stimulation animals were treated as chronic 
animals, but received an additional nicotine injection (1.5 mg/kg BW nicotine free base 
i.p.) 30 min before organ harvest. For all three sets of animals, following sacrifice brains 
were explanted and put on ice. A midline incision was executed and midbrain, 
hypothalamus, and hippocampus of either side were dissected. Tissues were immediately 
immersed in liquid nitrogen, then stored at -80 °C until further processing. 
 
Hepatocyte isolation for mRNA-Seq and for ATAC-Seq: Eight week-old male F1 
animals from control (TA) and nicotine-exposed fathers were anaesthetized using 
ketamine (100 mg/kg BW) and xylazine (10 mg/kg BW). The abdominal cavity was 
opened with a transverse incision below the rib cage. The portal vein was dissected with 
blunt forceps and a 26 G catheter needle was inserted. After cutting the vena cava inferior 
cranial of the liver, the organ was perfused firstly with 1X HBBS + 200 mM EDTA (10 
ml at 7 ml/min) and secondly with 50 ml DMEM containing collagenase type I (0.4 
mg/ml) at 7 ml/min. The liver was then removed from the abdominal cavity, put in a petri 
dish containing culture medium (DMEM, 20% FBS, 1X ITS, 1X Penicillin/Streptomycin, 
0.1 uM Dexamethasone, Sigma-Aldrich), and gently dissected to allow release of 
hepatocytes and supporting cells from connective tissue. Note that due to the 
disaggregation of the entire liver, mRNA abundance changes observed in a subset of 
hepatocytes (such as, for example, dying cells in drug-acclimated animals – Figure 2.14) 
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will be diluted out by the majority of unaffected hepatocytes.  After filtration through a 
70 µm nylon cell strainer, cells were washed twice with PBS 1X and once with culture 
media (centrifugation at 500 rpm for 5 min), and plated on a 0.1% gelatin-coated well. 
Hepatocytes were allowed to adhere to the bottom of the well for three hours. 
Nonadherent cells were then removed, and fresh culture medium (DMEM, 20% FBS, 1X 
ITS, 1X Penicillin/Streptomycin, 0.1 uM Dexamethasone, Sigma-Aldrich) was then 
added, initiating our time course (T0, T1, T3, T21 hours) at 37° Celsius and 5.0% CO2. 
Cells were collected after a PBS 1X wash by adding TriZol to the well for RNA 
experiments.  
 
RNA-Seq: Strand-specific libraries were prepared as previously described (Zhang et al., 
2012). Briefly, brain and liver were collected from nicotine-exposed and control F1 
males. Hepatocytes were isolated as described above. For the hippocampus, after 
sectioning of brain into 1-mm slices, areas of interest were identified according to the 
Mouse Brain Atlas by Paxinos and Franklin and dissected using 0.5-mm punches. 
RNA from brain and liver was isolated using standard TriZol protocols, followed by 
rRNA depletion (RiboZero kit, Illumina, Inc.). After first- and second-strand synthesis, 
adapters were ligated to fragments and amplified using multiplexed PCR primers. 
Libraries were sequenced on a NextSeq 500 platform from Illumina, Inc. Quality-
controlled reads were aligned to the reference genome (Mus musculus/mm10) with 
Bowtie2 and differential expression was calculated using DESeq2. For multiple 
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comparison adjustments, we used Holm-Bonferroni correction as a more conservative 
approach. 
RNA-Seq data are available at GEO, accession # GSE94059. 
 
ATAC-Seq: ATAC-seq libraries were prepared for 16 hepatocyte samples (4 NIC and 4 
TA animals, with each sample split into untreated and dexamethasone-treated aliquots) as 
previously described (Buenrostro et al., 2015) using the Nextera DNA Library 
Preparation Kit (Illumina). Libraries were paired-end sequenced on a NextSeq 500, and 
reads were aligned to mm10 using Bowtie2, v2-2.1.0 with the parameters -D 15 -R 2 -N 1 
-L 20 -i S,1,0.50 --maxins 2000 --no-discordant --no-mixed. Mitochondrial DNA and 
random chromosome mapped reads were removed, and PCR duplicates were removed. 
Genome browser images were generated from merged datasets with reads extended to 
150 bp, and normalized by total mapped reads per sample. For differential peak analysis, 
HOMER was used to identify NIC-specific peaks using TA peak files as background. 
ATAC-Seq data are available at GEO, accession # GSE92240. 
 
Liver histology: Livers were harvested from F1 males from nicotine-exposed and control 
fathers under various conditions (pre-treatment with nicotine 1.5 mg/kg BW 
intraperitoneal b.i.d. for 5 days or cocaine 15 mg/kg BW intraperitoneal b.i.d. or 
acetaminophen 400 mg/kg BW q.d. for 1 day) and washed with PBS. A 4-mm slice was 
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taken from each lobe and put in ice-cold 4% formaldehyde overnight. The next day, 
samples were dehydrated in a series of escalating ethanol solutions starting with 70% and 
ending with 100%, embedded in paraffin, and sectioned (4 µm slices), each section 
containing all four lobes, which were then mounted onto a glass slide. For H/E staining, 
slices were de-parafinized, incubated with xylene and a series of descending ethanol 
solutions. Incubation times for Mayer’s hematoxylin (Sigma-Aldrich) and 1% Eosin Y 
(Sigma-Aldrich) were 30 sec and 20 sec, respectively. After dewaxing of tissue, TUNEL 
staining was performed following the manufacturer’s recommendations (in Situ Cell 
Death Detection Kit, POD, Roche). Apoptotic areas per lobe were counted under a light 
microscope with 20X magnification at five different levels through the sample and 
analyzed with Image J.  
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C H A P T E R  III :  D I S C U S S I O N 
 
Study Summary 
 
Although the field of intergenerational inheritance of acquired traits has made major 
contributions to our understanding of the kind of information that entire organisms can 
potentially pass on to subsequent generations, it has remained elusive whether exposure 
to different environmental circumstances in one generation can impact offspring in a very 
specific manner depending on the stimulus the parental generation experienced, or more 
broadly in terms of a general metabolic response to conditions that are sub-optimal in the 
development of an organism. By investigating intergenerational paternal nicotine 
exposure as an example of a specific receptor-ligand interaction that has a major public 
health impact as one of the more common drugs of abuse, we were able to show that 
1) Paternal nicotine exposure can have a far reaching intergenerational impact in 
so far as it affects the survival of male offspring after LD50 application of drugs of abuse. 
In our mouse model, the effects on the next generation were restricted to male mice only. 
The phenotype was not associated with an alteration in addictive behavior such as self-
administration of the drug of abuse or addiction-related behavioral traits such as fear and 
anxiety response, but appeared to give offspring of nicotine-exposed fathers a fitness 
advantage as an overall increased survival rate on a population level, when re-introduced 
to nicotine or similar compounds such as cocaine. 
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2) The phenotypic effects of paternal nicotine exposure on male offspring were 
only evident after the F1 generation had been exposed to nicotine or other drugs of abuse 
themselves, which argues for (epi)genetic regulation that is dependent on at least two 
conditions, sufficient exposure to an environmental toxin in the paternal generation and 
re-exposure to the same or similar compounds in the next generation. We also observed a 
more general, primed XPG expression state of hepatocytes in naïve NIC offspring prior 
to drug exposure, which we speculate could lower the transcriptional threshold to allow 
them to respond to re-introduced changes in the environment more quickly.  
3) Our paradigm of chronic paternal nicotine exposure revealed a non-specific, 
metabolic response in offspring and not, as was our hypothesis, a specific addiction 
phenotype mediated through nAChRs either centrally or in the periphery. This means that 
information about environmental conditions during one generation as investigated in our 
experimental paradigm are passed on to subsequent generations as a general quality-of-
life experience, which can then prime the offspring to be better equipped to deal with 
such adverse conditions upon re-exposure in the future. 
4) Our model of paternal nicotine exposure offers the scientific community a 
better-defined paradigm than the general diet-based approaches, as it focusses on a 
specific receptor (nAChR) ligand (nicotine) interaction. This can be useful for a variety 
of experiments in the future, which require eliminating confounding factors, and can help 
to dis-entangle the extent, to which various factors contribute to an intergenerational 
phenotype. 
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Contextual Interpretation of Results 
 
In the following section, we shall provide scientific background and context that may be 
helpful in the interpretation of our data. Although we performed an extensive screen in 
F1 offspring to establish a robust read-out for our paternal nicotine exposure paradigm, 
there are unanswered question that remain left to be solved by future experiments. This 
section may also assist in the composition of future studies by considering what has been 
done by others in the field. After all, “nos esse quasi nanos gigantum umeris insidented” 
as Bernard of Chartres once said. 
 
Nicotine-specific versus non-specific F1 Phenotype 
Much to our surprise, specific nicotine-mediated stimulation of nAChRs in the paternal 
generation did not result in a nicotine-related behavioral phenotype in the F1 generation. 
However, it is worth noting that we performed only a limited number of behavioral tests. 
We investigated the rewarding potential of nicotine in offspring coming from nicotine-
exposed fathers compared to control offspring in a classic self-administration experiment, 
which is the gold standard in the field. We also took a closer look at potential differences 
in the somatic effects of nicotine in the F1 generation as assessed by locomotor activity 
over time. Finally, we studied potential phenotypes of nicotine that are related to anxiety-
spectrum disorders with elevated plus maze experiments. In none of these behavioral 
tests did we find any evidence that would allow us to conclude that paternal nicotine 
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exposure has a specific nicotine-mediated effect on the F1 generation. However, we did 
not test memory or learning in F1 offspring. It is known that exposure to nicotine for a 
short amount of time can improve short-term memory both in animal models of 
schizophrenia (Hambsch et al., 2014) and human cohort studies, in which participants 
received either nicotine gum (Phillips and Fox, 1998) or transdermal nicotine patches 
(Poltavski and Petros, 2005) (Froeliger et al., 2009). These effects are probably mediated 
by the homomeric α7 subtype of nAChRs in the hippocampus (Hambsch et al., 2014; 
Weiss et al., 2007). While we have no phenotypic or behavioral evidence for a 
hippocampal connection, RNA sequencing studies of the hippocampus of offspring from 
nicotine-exposed and control fathers revealed no significant changes on the 
transcriptional level, specifically for neither α7 nor other nAChR subunits, but also over 
the entire transcriptome, and, therefore, suggest that the hippocampus and memory-
related functions in F1 offspring may not be the major target of intergenerational nicotine 
effects. 
 
It should be noted that other studies have found such differences in complex cognitive 
learning abilities in the F1 generation of nicotine-exposed parents. In particular, there is 
one study performed in rats (Renaud and Fountain, 2016) that is of interest. F1 generation 
rats that came from nicotine-exposed parents and were exposed to nicotine themselves 
during adolescence did worse in special recognition and learning experiments than F1 
rats that received nicotine during their adolescence, but came from parents that had not 
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been exposed to nicotine (control). This study, however, has many flaws. Firstly, it 
exposed both male and female parents to nicotine prior to mating, thus may have 
confounded effects of nicotine that are transmitted through the paternal side of transfer 
versus maternal effects. Secondly, in contrast to our study, the researchers did not 
investigate the molecular level of intergenerational nicotine exposure, but focused their 
attention on only the behavior. Without having an additional layer of evidence such as 
changes on a cellular or molecular level, a sample size of 15 test subjects per condition is 
far too small to make claims about intergenerational phenotypes. To achieve a statistical 
power of 80% and assuming an effect size of 0.5, one would have to include at least 50-
60 animals per group to be able to reliably calculate statistical significance. Thirdly, 
nicotine was administered to the animals through intraperitoneal injection twice a day, 
which could in itself act as a major stressor and elicit behavioral and molecular changes 
that can be passed on to the next generation. Thus, it is conceivable, that the observations 
made in the F1 generation have nothing to do with nicotine, but rather are the results of a 
series of physical injuries that resulted in a general stress response in these animals. This 
is one reason of why we decided to administer nicotine to the animals in their drinking 
water, as this reduces the impact of confounders such as external or concomitant stressors 
introduced, for example, by i.p. injections. It is, however, nice to see that even at this 
level of statistical trends, there is a “two-hit requirement”, i.e., both the parental 
generation and the F1 generation have to be exposed to nicotine to see an effect, which is 
what we observed in our paradigm, as well.  
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A much better designed study that drew a lot of attention in the scientific community 
showed a receptor-ligand specific effect in offspring as response to paternal fear 
conditioning using a specific odor, acetophenone, combined with electric foot shocks 
(Dias and Ressler, 2014). Surprisingly, both the F1 and F2 generations showed increased 
sensitivity to this odor, which could morphologically be traced back to a specific 
olfactory receptor (Olfr151) in the brain with hypo-methylation of the Olfr151 region in 
sperm of F0 and F1 males. As interesting as these findings appear to be at first glance, a 
major flaw of this experimental paradigm is again the small sample size. Researchers, 
who conducted the study, used a sample size of only 4 for their methylation analysis. Our 
lab has shown in the past that small sample sizes lack statistical power, as they cannot 
differentiate between true positives and false over-representation of a certain sub-
population within the relatively wide methylation variability due to intrinsic epi-variation 
of the methylation state of specific genomic regions (Shea et al., 2015). On the other 
hand, this olfactory receptor study validated the observed receptor-ligand specificity with 
in-vitro fertilization (IVF) experiments, in which sperm from either a stimulus-exposed or 
control father was injected into a control oocyte and the embryo transferred into a 
pseudo-pregnant control foster female. Nevertheless, the findings of this study stand 
rather alone in a sea of support in favor of a more generalized offspring response.  
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Gender Difference in F1 Phenotype 
Before we discuss potential reasons for the gender-associated difference in F1 phenotype 
expression, it shall be noted that phenotype preferences of one or the other gender are 
commonly seen in diseases such as cancer, genetic disorders such as mutations of 
metabolic pathways, or multifactorial pathologies such as cardiovascular diseases, 
neurological, and psychiatric disorders. It is, however, of utmost importance to 
understand, what the underlying causes for these gender differences might be, even more 
so in the context of intergenerational epigenetics, where special caution is required to 
account for a plethora of potential confounders. The observed phenotype in the F1 
generation is only detectable in male offspring from nicotine-exposed fathers. Initially, 
we tested both males and females. The locomotor activity assay did not show a 
pronounced phenotype in female F1s from nicotine-exposed fathers. When we performed 
the nicotine self-administration experiment to study the rewarding effects of nicotine in 
the F1 generation, it became clear that female mice at an age of seven to eight weeks 
post-natum are not readily trainable in the nicotine self-administration paradigm. It is not 
so much the nicotine administration itself that causes the issue, but rather the fact that 
female mice cannot be conditioned to reproducibly prefer the active portal over the 
inactive portal during the training with sucrose pellets. The preference of the active portal 
over the inactive portal should at least lie in the range of 1:5 to 1:10 (Fowler and Kenny, 
2011), which we did not achieve in female test subjects, so they could not be included in 
this study. In addition to those negative results, naïve females did not display a survival 
difference between F1s from nicotine-exposed fathers and control fathers. This let us 
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conclude that there is no obvious behavioral phenotype in F1 females from nicotine-
exposed fathers in our experimental model and in the conditions that we tested. It is not 
uncommon that transgenerational studies reveal a sex preference of the observed 
phenotype in subsequent generations. There are many possible explanations for this 
phenomenon, of which only a few shall be mentioned.  
 
Firstly, the expression of a certain phenotype could be dynamic over generations rather 
than a sharp yes-or-no answer. This means that it is completely conceivable that a certain 
phenotype could be expressed more quickly in one gender, but needs the persistent 
exposure of several consecutive generations in the other sex. In this scenario, sex 
differences are not true positives, but depend on experimental conditions such as the 
length of observation post-exposure, the level of granularity of what is considered a 
phenotype, and the dynamic resolution capacity of equipment used to observe a particular 
phenotype. For example, changes in the expression level of genes may serve as a 
phenotypic biomarker for a molecular biologist, but have less meaning to a behavioral 
scientist, if these transcriptional changes do not result in an alteration of behavior in the 
test subjects at a given time point, when the test is performed. Thus, in this case, gender 
differences are observation-based. 
 
Secondly, it is possible to imagine a scenario, in which intergenerational traits are not 
completely penetrant on a population level, but rather need to pass a certain threshold in 
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an individual to display a phenotype that is readily observable. In our case, the 
differences in hormone levels between males and females could raise the bar for females 
to show the exact same liver phenotype that we see in males. We found in our ATAC-Seq 
data that Nuclear Hormone Receptor (NHR) responsive elements in the genome are more 
accessible in male offspring from nicotine-exposed fathers. We did not look at female 
F1s, but it is known that, for example, estrogen and estrogen receptor alpha are liver-
protective in that they stimulate mitochondrial function and metabolism (Madak-Erdogan 
et al., 2016). Estrogen also increases the expression of NHRs such as Peroxisome 
Proliferator-Activated Receptor Gamma (PPARγ) and Nuclear Respiratory Factor 1 
(NRF1) in liver and other tissues (Hamilton et al., 2016; Ribas et al., 2010). As males 
have very low levels of estrogen under physiological conditions, this difference and the 
altered regulation of associated pathways could account for the observed gender gap. 
Additionally, growth hormone can induce nuclear translocation of Hepatocyte Nuclear 
Factor-4alpha (HNF-4α), Pregnane X Receptor (PXR), and Retinoic X Receptor alpha 
(RXRα) and up-regulation of CYP3A5, an important cytochrome P450 subunit involved 
in metabolism of many xenobiotics, an effect that is much more pronounced in female 
primary hepatocyte culture than in male primary hepatocyte culture (Thangavel et al., 
2013). This gender difference is also true for other cytochrome P450 subunits such as 
CYP3A4 and appears to be the result of an increased rate of nuclear translocation of 
HNF-4α, PXR, and RXRα in females upon stimulation with growth hormone or 
corticosteroids (Dhir et al., 2006; Thangavel et al., 2011). An interesting fact in this 
context is that growth hormone release from the pituitary gland follows two very distinct 
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patterns in males (pulsatile with peaks every 3-4 hours in rats) and females (constant), 
respectively (Agrawal and Shapiro, 2001; Dhir et al., 2006; Waxman and Holloway, 
2009). The same general male-peak v female-constant patterns can be observed in mice 
(MacLeod et al., 1991) and humans (Veldhuis, 1998). Mechanistically, calcium 
stimulates the release of growth hormone from cells in the pituitary gland. The calcium 
response of these growth hormone cells is more pronounced in males than in females 
with this difference being partly caused by gonadal steroids as a feedback loop in human 
adults (Sanchez-Cardenas et al., 2010), which again are different between males and 
females.  
Another possibility is that metabolic pathways such as the one-carbon donor S-
adenosylmethionine (SAM) pathway, which provides the donor for cytosine methylation 
and can be altered by stress levels (Saunderson et al., 2016), or the metabolism of alpha-
ketoglutarate and Fe(II), which are involved in de-methylation processes through 
dioxygenase enzymes (TETs) (Ito et al., 2010; Tahiliani et al., 2009), are so different 
between males and females due to the higher levels of, for example, estrogen in female 
mice, that an altered cytosine methylation state of certain gene promoters or enhancers of 
xenobiotic processing or metabolic genes in the liver changes the phenotypic outcome 
between the two genders. All these described factors could alter the threshold of when 
molecular changes become detectable as a phenotype. In all these cases, observed gender 
differences would only be secondary to an underlying confounder or primary cause and 
could be resolved and standardized, when these factors are taken into account in the 
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experimental design, which would require a much broader mechanistic approach than 
what we applied in our experimental paradigm. 
 
Thirdly, the gender differences that we saw in our study could be true. If this is the case, 
then the mediating entity of the observed phenotype must either lie on the sex 
chromosomes or as a second possibility could still be encoded on the autosomes, but 
would functionally regulate something that is encoded on the sex chromosomes. The 
former scenario is rather unlikely, as neither any of the nAChRs nor any of the CYP P450 
enzymes are encoded on sex chromosomes. In fact, human α4 and β2, two of the more 
common subunits involved in nicotine reward and addiction, are encoded on 
chromosomes 20 and 1, respectively, whereas in mouse they are located on chromosomes 
2 and 3, respectively. The α7 subunit, which is expressed in the hippocampus and 
surprisingly also in mature sperm, is encoded on chromosome 15 in humans and on 
chromosome 7 in Mus musculus. Thus, we are left with the latter scenario, for which 
there is some evidence in the literature. For example, in order to compensate for the 
additional X chromosome in females, one of them is usually inactivated during early 
embryonic development in a non-random manner (Heard et al., 1997; Lyon, 1961; Tan et 
al., 1993), a process largely influenced by the so called X chromosome controlling 
element (Xce), an approximately 1.9 MB region on the X chromosome that acts in cis 
and amongst others comprises the long non-coding RNA Xist (Calaway et al., 2013; 
Chadwick et al., 2006; Thorvaldsen et al., 2012). Researchers have found that this region 
acts as a sponge that can bind factors needed for dosage compensation (Blewitt et al., 
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2005; Calaway et al., 2013). It is conceivable that such factors, be it proteins in the form 
of transcription factor activators or repressors and similar, or be it small and long RNA 
entities, would then be under-represented in other regions of the genome, which could in 
turn change the expression levels of coding and non-coding sites in those regions. To 
provide additional support for this hypothesis, factors located on autosomes are known to 
be involved in the X-inactivation process, as for example Xiaf1 and Xiaf2 on mouse 
chromosome 15 (Percec et al., 2002). Again, the expression of Xiaf1 and Xiaf2 and their 
dys-regulation in the male genome, respectively, could be involved in other regulatory 
processes that have yet to be discovered and thus, could account for some of the gender 
differences that we observed in our mouse model of chronic paternal nicotine exposure. 
Interestingly, the neo-natal brain is particularly prone to X-inactivation that under-
represents the paternal X chromosome (Wang et al., 2010). The brain in general is an 
organ that presents with strong allele-specificity in the scope of imprinting. For example, 
the Igf-2 locus is highly involved in adult neurogenesis in the hippocampus, particularly 
in the sub-ventricular zone and the sub-granular zone (Bracko et al., 2012). Igf-2 is solely 
expressed from the paternal allele in neural stem cells, while the maternal allele is 
completely shut off (Ferron et al., 2015). It has been shown that maternal caloric 
restriction led to an increase in Igf-2 expression in the hippocampus of female F1s and 
female F2s, but not in males (Harper et al., 2014). Again, our RNA sequencing results 
from male hippocampus did not show significant differences between male offspring 
from nicotine-exposed and control fathers, but at the same time we did not look at F1 
females from nicotine-exposed and control fathers. Again, it is theoretically conceivable 
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that gender differences observed by us and others are based on true biological processes 
due to altered dosage compensation of the X chromosome or imprinted alleles in specific 
organs or tissues between males and females. In this scenario as well, a broader 
mechanistic approach is required to be able to unveil these pathways. 
 
Survival Phenotype and Nuclear Hormone Receptor Pathways 
In our experimental paradigm, we saw an up-regulation of xenobiotic processing genes 
(XPG) on a transcriptional level in the liver of naïve male F1 offspring from nicotine-
exposed fathers compared to offspring from control fathers as determined by RNA-
sequencing experiments. In a time course experiment, in which we treated PMHs with 
nicotine over a period of 24h, this up-regulation in NIH hepatocytes relative to control 
hepatocytes could be observed throughout each time point, but did not increase with the 
time being exposed to nicotine. It is interesting that naïve hepatocytes show a de-
repression of XPGs without any previous exposure to nicotine. We made the same 
observation, when we looked at liver samples from NIC and control offspring. Although 
the differences were not as pronounced as in the in-vitro setting due to greater inter-
individual variability, NIC offspring did display a higher baseline expression level of 
XPGs even in a naïve state without major differences in additional up-regulation after 
nicotine exposure between F1s from nicotine-exposed and control fathers. Confirmation 
of Cyp2a5 expression levels, the major metabolic subunit for nicotine, in liver samples 
from NIC (n=6) and control (n=4) offspring by qRT-PCR showed significant up-
		
95	
regulation of this gene in NIC offspring (Figure 2.10C). These results, however, raise the 
possibility that there are several mechanistic pathways that need to act in a sequential or 
synergistic manner after xenobiotic exposure to lead to the observed survival phenotype. 
 
ATAC-sequencing data showed that chromatin was generally more accessible across the 
entire genome in hepatocytes from F1 males of nicotine-exposed fathers (NIC 
hepatocytes). In addition, we observed 1861 peaks of chromatin accessibility that were 
significantly higher in NIC hepatocytes than in control hepatocytes, amongst them being 
peaks near genes such as Nr1h3 (CAR, Constitutive Androstane Receptor) and Nr1i2 
(PXR, Pregnane X Receptor).Nr1h3 and Nr1i2 belong to the nuclear hormone receptor 
(NHR) family and regulate expression levels of metabolic and XPG genes. CAR and 
PXR are especially closely related to each other. These NHRs form heterodimers with 
retinoid-X receptor (RXR) and thus, activate gene transcription upon translation into the 
nucleus from the cytoplasm. NHRs that induce the expression of Phase I and Phase II 
biotransformation genes such as members of the Cytochrome P450 super-family 
responsible for redox and hydrolytic reactions (Chen et al., 2003; Itoh et al., 2006; 
Kojima et al., 2007; Sueyoshi and Negishi, 2001), and glucuronosyltransferases and 
sulfotransferases that are involved in conjugation reactions (Sugatani et al., 2001; Xie et 
al., 2003), as well as multi drug transporters (belonging to Phase III of the detoxification 
reaction) (Burk et al., 2005; Geick et al., 2001), have a highly conserved N-terminal 
DNA binding domain comprising eight cysteines (Fang et al., 2012; Giguere et al., 1988) 
and interacting with hormone response elements (HRE) in the genome, as well as a 
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ligand domain with three layers of alpha-helices that are able to form such flexible and 
big enough a pocket to allow binding of a variety of xenobiotic molecules (Evans, 1988; 
Noble et al., 2006; Watkins et al., 2001). This promiscuity towards xenobiotics enables 
NHRs to respond to a broad spectrum of substances that get introduced into the body. For 
example, the well-known anti-epileptic drug phenobarbital (PB) leads to de-
phosphorylation of threonine 38 upon binding to CAR and its subsequent translocation 
from the cytoplasm into the nucleus, where it induces up-regulation of CYP2B10 
expression (Mutoh et al., 2009). Induction of the Cytochrome P450 enzyme complex by 
PB can affect the bio-availability of other drugs and compounds as well, as they use the 
same bio-transformation pathways and thus, will be metabolized and removed from the 
system more quickly. 
 
In our experimental paradigm of primary hepatocyte culture, however, CAR and PXR are 
up-regulated at a naïve state in NIC hepatocytes compared to control and no further up-
regulation is observed upon in-vivo nicotine or cocaine stimulation prior to the perfusion 
and hepatocyte isolation. Interestingly, the observed difference on a transcriptional level 
in-vitro does not translate into an in-vivo phenotype, as naïve animals do not show a 
survival difference, when challenged with a variety of nicotine concentrations ranging 
from very low to very high (dose-response curve). An alteration in the survival rate of F1 
males from nicotine-exposed fathers is only detectable in animals that were chronically 
exposed to low levels of nicotine prior to the LD50 challenge (chronic F1 cohort) and, at 
the same time, whose hepatocytes do not increase gene expression of cytochrome P450 or 
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NHR genes much further beyond what is seen in naïve NIC hepatocytes. This 
discrepancy between what is seen on a transcriptional level and what ultimately amounts 
to a measurable phenotype could not be resolved in our experimental paradigm. In-vivo 
analysis of liver samples showed large variability, which is not surprising at all 
considering that these intergenerational effects probably only manifest on a population 
level as a whole, i.e. the penetrance is most certainly not 100%. To phrase this argument 
differently, if intergenerational effects were so penetrant that they could affect every 
single individual of a population coming from a father that had been exposed to a 
particular stimulus, then every minor single change in the environment could potentially 
be so detrimental and lethal to an entire species, that we as human beings would not be 
around anymore to perform this type of experiment. Inter- or transgenerational effects 
can – per definitionem – only be minor and be of significance only for a population in its 
entirety. Thus, we speculate that there was probably an evolution of cellular and 
organismal response mechanisms that are able to suppress whatever effect the 
environment may have, similar to how piRNAs are able to silence transposable elements, 
which were introduced into the genome as parasitic entities, to ensure integrity and 
stability of the germline and, by doing this, propagate the fitness of the gene pool. This 
may be the reason why effects of paternal nicotine exposure were more pronounced in in-
vitro hepatocyte cultures than in in-vivo livers. In tissue culture, there are no supra-
cellular control mechanisms, but only the cells themselves that have to respond to 
whatever stimulus is imposed directly upon them. It is also worth noting that culture 
medium for hepatocyte primary culture contains dexamethasone to improve survival of 
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cultured cells, which in itself has been shown to activate Cytochrome P450 enzymes and 
inhibit hepatocyte apoptosis (Hunter et al., 2017; Zhao et al., 2015). The dexamethasone 
effect could, thus, mask the additional benefit of low level chronic exposure to nicotine or 
cocaine in those hepatocytes. To further investigate the influence of dexamethasone on 
primary hepatocyte gene expression levels and survival, control experiments without 
dexamethasone can be performed simultaneously to the usage of standard culture 
conditions. As a summary, it is not unexpected that in-vitro primary hepatocyte 
conditions do not exactly replicate what happens in-vivo. 
 
Our TUNEL assay that stains apoptotic cells and the associated finding that F1 males 
from nicotine-exposed fathers show significantly lower levels of apoptotic cells around 
the central vein than control F1 males, but only after chronic exposure to cocaine, but not 
nicotine, indicate that there must be additional factors that contribute to the F1 survival 
phenotype that could, when discovered, explain the discrepancy between transcriptional 
level and phenotype. It is a known fact that cocaine is hepatotoxic (Thompson et al., 
1979), mostly mediated through its main metabolites norcocaine, norcocaine nitroxide, 
and N-hydroxynorcocaine (Ndikum-Moffor et al., 1998). It also is not surprising that our 
TUNEL assay post chronic nicotine exposure did not result in apoptotic cells in the liver 
after nicotine exposure, as nicotine is not known to be hepatotoxic. We, therefore, 
focused on cocaine-mediated hepatotoxicity to determine differences in cell survival 
between groups. It is, however, remarkable that chronic cocaine exposure in F1 males 
from nicotine-exposed fathers resulted in significantly reduced hepatotoxicity of cocaine 
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and a higher survival rate of NIC offspring after short-term exposure to either nicotine or 
cocaine followed by LD50 of nicotine or cocaine. Extrapolating the survival phenotype on 
an organismal level, we speculate that altered gene regulation could result in a survival 
phenotype on a cellular level, i.e., the more hepatocytes survive low level exposure to a 
xenobiotic, the more cells can metabolize the very same xenobiotic, when it is applied as 
an LD50 dose. This hypothesis is supported by the fact that male offspring from nicotine-
exposed fathers metabolize nicotine into cotinine faster than control offspring. It will be 
important to expand the histologic assessment of liver samples to the quantification of 
necrotic areas in the liver, as they may show a different distribution that what we saw in 
our TUNEL assay. Acetaminophen is highly hepatotoxic and causes necrosis in the liver 
after a single dose of 400 mg/kg BW. As Acetaminophen is a non-steroidal anti-
inflammatory drug (NSAD), determining the phenotypic response in livers from NIC and 
control F1s will help to address the underlying mechanisms beyond the drugs of abuse 
that were used in this study. 
 
As CAR and PXR also metabolize endobiotics, it is scientifically conceivable that other 
endogenous hormones, such as estrogen as the major sex hormone in females, could have 
an additional impact on the response of NHRs to xenobiotics such as nicotine, alter 
survival outcome post nicotine LD50 applications, and again provide an explanation for 
the gender differences that we described above. Furthermore, the sympathetic nervous 
system plays a prominent role in hypothalamic stimulation and pituitary release of growth 
hormone and thus, influences the level of corticosterone and testosterone in the blood 
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circulation (Kot and Daniel, 2011; Sadakierska-Chudy et al., 2013), which in turn have 
an impact on cytochrome P450 expression, as was elaborated above. In addition, 
corticosteroids such as dexamethasone increase hepatocyte survival in culture through the 
same CAR, PXR, RXR pathways. Following the argument that the hypothalamus-
pituitary-adrenal axis (HPA axis) impacts cytochrome P450 expression through growth 
hormone, corticosteroids, and NHR interactions, the increased survival in F1 males from 
nicotine-exposed fathers after short-term F1 exposure to a certain drug of abuse could 
have a general stress response as the underlying mechanism. Further experiments need to 
be performed to determine hormone levels in F1s before and after exposure to nicotine or 
cocaine. But it is a viable hypothesis to assume that the non-specific survival phenotype 
that we detected in our experimental paradigm is the result of an altered regulation of the 
NHR and the HPA axis.  
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Potential Mechanisms of F1 Phenotype 
Our phenotypic study of behavioral and molecular changes in F1 males from nicotine-
exposed fathers compared to control offspring revealed that  
1) naïve NIC offspring show up-regulation of XPGs in the liver and in PMH 
culture in-vitro and  
2) NIC offspring survive LD50 doses of nicotine or cocaine at a higher percentage 
only after pre-exposure to either one of these drugs of abuse.  
The discrepancy between the transcriptional results and the observed functional 
phenotype could not be resolved in our study. Nevertheless, we speculate that there may 
be several underlying mechanisms that could account for the missing link between 
transcriptome and behavioral phenotype. 
 
Firstly, Cotinine-ELISA data reported in this work strongly suggest that NIC offspring 
are, indeed, able to functionally metabolize nicotine more quickly and, thus, clear the 
system of harmful toxins more effectively than control offspring, despite the lack of 
additional transcriptional changes in nicotine or cocaine pre-exposed animals. As stated 
previously, Cyp2A5 is the enzymatic subunit in mice that metabolizes nicotine (Li et al., 
2013). We hypothesize that the raised expression level of XPGs in a naïve state could be 
sufficient to lead to higher levels of functional protein, which in turn could more readily 
metabolize nicotine, when it is introduced into the organism. As there is not always a 
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good correlation between mRNA abundance and translated protein levels due to post-
transcriptional and translational regulatory mechanisms (Fagerberg et al., 2014; Ingolia, 
2014), it will be important to employ techniques such as ribosomal footprinting to 
determine translation rates and further substantiate the claim that an increased baseline 
expression of XPGs can result in more active protein without additional up-regulation of 
gene expression in the pre-exposed state. In addition, Cytochrome P450 activity assays 
will allow us to investigate the level of functional protein in NIC and control PMHs. 
Depending on the half-life of these cytochrome P450 proteins, it is reasonable to think 
that they could remain in the cell for quite some time after translation, which would 
decrease the need to continuously transcribe XPGs after having accumulated a sufficient 
baseline amount of active protein.  
Circular RNAs (CircRNAs) could serve as another way for cells to stabilize transcription 
products by circularizing their 5’ and 3’ ends and store them in the cytoplasm until they 
are used for translation (Granados-Riveron and Aquino-Jarquin, 2016; Memczak et al., 
2013). Using the above mentioned ribosome footprinting technology, researchers have 
recently shown that circRNAs are indeed associated with active ribosomes, thus raising 
the possibility that these circRNAs are transcribed into functional proteins (Pamudurti et 
al., 2017). XPG mRNA products may be stored as circRNAs in a cell until additional 
stimuli such as the exposure to nicotine or cocaine activate translational pathways. 
Furthermore, circRNAs have been shown to display regulatory functions. Sex-
determining region Y (SRY), for example, can be present as circRNA in testes that can 
act as a sponge for microRNA-138 (miRNA), thus affecting regulatory signals that these 
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miRNAs may otherwise promote (Hansen et al., 2013). It is possible that circRNA-based 
mechanisms regulate XPGs post-transcriptionally. CircBase (www.circbase.org) is an 
online database developed by Nikolaus Rajewsky and his lab in collaboration with the 
Max-Delbrück Center for Molecular Medicine in Berlin, Germany, that provides an 
excellent catalogue of all known circRNAs and also serves as a prediction tool for new 
circRNA entities (Glazar et al., 2014).  
As small RNAs such as miRNAs have been shown to regulate Cytochrome P450 subunit 
expressions (Zanger and Schwab, 2013), an additional investigation of small RNA 
profiles in NIC versus control PMHs may contribute to a better mechanistic 
understanding of the observed phenotype. PXR, for example, has a miRNA recognition 
site in its sequence, to which miRNA-148a can bind and inhibit PXR translation, thus 
changing the level of active CYP3A4 in human liver (Matsuda et al., 2008). As our 
nicotine time course experiments in PMH culture did not lead to additional changes in 
Cytochrome P450 or NHR mRNA levels beyond the ones that are already present at 
baseline, cirRNAs and small RNAs could provide further insight into the downstream 
regulatory mechanisms that ultimately lead to increased survival in NIC offspring after a 
challenge with high doses of nicotine or cocaine. 
 
Secondly, in addition to a significant up-regulation of XPGs in naïve NIC PMHs, we also 
observed changes in metabolic genes, most prominently within lipid metabolism 
pathways (Figure 2.9E). These findings further substantiate the assumption that F1 
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offspring may respond to paternal nicotine exposure in a rather non-specific manner. 
However, comparing the lipid metabolism genes that are affected in our nicotine 
paradigm with the ones that displayed major changes in a previous study from the Rando 
lab, in which the paternal generation was exposed to low-protein or control diet (Carone 
et al., 2010), we saw little to no overlap. The diet paradigm resulted in lipid metabolism 
gene changes that mainly affected the cholesterol synthesis pathway, whereas in our 
study metabolic genes, whose expression levels were significantly altered, are involved in 
a variety of lipid metabolism pathways, but not in cholesterol synthesis. Although this 
comparison appears to be intriguing at first, it shall be noted that the experimental design 
of the two paternal exposure paradigms was quite different. In Carone et al., microarray 
analysis was performed on dissected livers from 3-week old F1 pups that had not been 
weaned from mother’s milk yet, while our nicotine study performed RNA sequencing 
experiments on 8-week old, mature F1 animals that had been on regular diet for five 
weeks. As pre- and post-weaning liver metabolism differs rather significantly (Renaud et 
al., 2014), no meaningful conclusions between these two datasets can be drawn. We, 
instead, investigated the response of F1 males from nicotine-exposed and control fathers 
to glucose and insulin injections and observed a trend towards insulin-hyposensitivity in 
NIC offspring (Figure 2.10A,B). As the sample size in this experiment was small, we 
advise caution in interpreting these data. On the other hand, it has recently been shown 
that NHR pathways can, indeed, regulate the storage of fat-droplets in C. elegans (Li et 
al., 2017). Peroxisome Proliferator-Activated Receptors (PPARs) are a sub-family of 
NHR with known functions in metabolic homeostasis, lipid, and glucose metabolism 
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(Montagner et al., 2016; Regnier et al., 2017). PPARs often function as heterodimers with 
other NHRs such as Retinoic acid receptor-related Orphan Receptor alpha (RORα) (Kim 
et al., 2017) or RXR to ensure metabolic homeostasis (Evans and Mangelsdorf, 2014). As 
described above, PXR and CAR also need to form heterodimers with NHRs such as RXR 
to translocate into the nucleus and initiate gene expression upon DNA binding. In our 
ATACseq experiments, RXRα showed increased signal in NIC hepatocytes, so RXRs 
can be imagined as the promiscuous binding partner to a variety of NHRs. As NHRs 
function in a complex network of interactions with each other, we hypothesize that the 
non-specific phenotype response in F1 males from NIC fathers is not limited to the mere 
processing of nicotine or cocaine, but also includes basic functions of metabolic 
pathways such as the observed up-regulation of lipid metabolism genes. Future studies 
will focus on this aspect of our transcriptional analysis and try to understand the network 
biology behind it. 
 
Thirdly, we speculate that a primed state of increased XPG and NHR expression will lead 
to increased survival of hepatocytes, when exposed to drugs of abuse. Interestingly, Liver 
X Receptor (LXR) showed increased ATAC signal in NIC hepatocytes. PPARγ is the 
heterodimeric co-receptor for LXR (Oberkofler et al., 2003). As such, LXR displays anti-
inflammatory activity (Spillmann et al., 2014; Zelcer and Tontonoz, 2006), which can 
mitigate pro-inflammatory challenges (Ghisletti et al., 2007). It is possible that the up-
regulation of LXR and PPARγ protect hepatocytes from NIC offspring against 
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inflammation and subsequent cell death. The decrease in apoptosis after cocaine exposure 
in livers from NIC offspring as determined by TUNEL staining could indicate that this 
protective effect may apply to hepatocytes in a much boarder manner including various 
drugs of abuse or other xenobiotics. A challenge with acetaminophen did not result in 
significant differences in apoptosis between the two cohorts, but considering the non-
specific nature of our F1 phenotype there may as well be a difference in the overall level 
of necrosis that we did not assess in our study. If, for example, NIC offspring showed 
lower plasma levels of pro-inflammatory markers such as CRP, γGT, and 
aminotransferases (ALT, AST) after a xenobiotic challenge, this could indicate a 
protective effect of NHRs that is not necessarily detectable on the histologic level of cell 
death, as these hepatocytes may never progress to this very late stage of inflammation-
mediated response. In this study, we did not look at intermediate states of inflammation 
that could ultimately lead to cell death. It will be of utmost importance to perform in-vitro 
cell survival assays and measure pro- and anti-inflammatory cytokines in culture medium 
supernatant and in-vivo in the presence or absence of NHR agonists to gain more insight 
into the link between NHR and XPG up-regulation and improved cell survival as 
observed in our IHC approach.  
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Limitations of this Work 
 
Despite the novelty of this study’s findings, there are a few shortcomings that may have 
prevented us from fully uncovering the underlying mechanisms of the increased survival 
phenotype in F1 males from nicotine-exposed fathers after short-term F1 exposure to a 
drug of abuse.  
 
1) In order to address the observed gender difference, we should have included 
female test subjects in our primary hepatocyte in-vitro assay. This could have allowed us 
to compare transcriptional profiles between males and females and link them to the 
observed phenotype. It shall be noted at this point, that females did indeed display a 
metabolic phenotype in term of increased body weight of females from nicotine-exposed 
fathers after the pre-conditioning period with sucrose in the nicotine self-administration 
paradigm. The effect was not significant, but considering that we only included a small 
number of females due to conditioning issues of the female test subjects and the fact that, 
during the self-administration experiment, the 24h food intake is restricted to 85-90% of 
the animals’ normal food intake assuming an average 25g standard mouse, this result 
could be worth pursuing. 
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2) As it became increasingly clear over the course of the study that the survival 
phenotype that we observed in F1 males from nicotine-exposed fathers may be associated 
with differential regulation of CYP P450 genes and NHR response, we should have 
measured hormone levels in the bloodstream both in F1 males and females. Cortisol, 
testosterone, estrogen, growth hormone, and others may as well be involved in 
establishing this phenotype.  
 
3) Our study focused purely on the F1 generation. This is reasonable, when one 
takes into account the sample sizes that are required to draw robust conclusion from such 
difficult an experimental paradigm. It is far better to try to obtain a complete dataset from 
one aspect of a biological process than getting fragmentary information from several 
different angles of a pathway. In order to provide a mechanistic explanation for the 
observed phenotype not only in the F1 generation, but also on the intergenerational part 
of the question, it is essential to investigate potential ways of transmission of this type of 
information about environmental exposures from one generation to the next. As stated in 
the Introduction, this was not within the scope of this study, but needs to be addressed, 
nevertheless, in the long term. 
  
		
109	
Future Outlook 
 
This study was able to answer some of the questions surrounding the intergenerational 
inheritance of acquired traits through the paternal side. We have found a generalized, 
non-specific, metabolic response in F1 males. Future studies will focus on the underlying 
mechanisms that transmit information about paternal nicotine exposure onto subsequent 
generations. These experiments will include in-vitro fertilization (IVF) and embryo 
microinjections to identify the entities that are responsible for information transfer 
independent of cofounding factors within the variability of in-vivo conceptions. 
Experiments will also include offspring of both genders and investigate more closely the 
influence of hormone levels on and the role of NHRs in the establishment of an F1 
survival phenotype by measuring Cyp P450 enzyme activity, inflammation markers in 
blood plasma and in-vitro, and using NHR agonist and antagonists to investigate a 
mechanistic link between transcriptome and phenotype. 
It appears to be the case, that the HPA axis is involved in this concerted response. It will 
be important to include neonatal steroid manipulation experiments in the scope of future 
research, as they can shed more light on role of the HPA axis in this phenotype. Another 
possibility is to use gene editing technologies such as CRISPR/Cas9 to create autosomal 
sites of SRY and defined sequences within Xce to further investigate the “sink” 
hypothesis mentioned above.  
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The subtle, but distinct difference in sucrose pellet self-administration in male NIC 
offspring without differences in total body weight between the two cohorts could indicate 
a central role for appetite regulation or lipid metabolism. In addition, female F1s from 
nicotine exposed-fathers showed a greater increase in body weight, when subjected to the 
sucrose conditioning phase of the self-administration paradigm. Assessing 24h food 
intake over a longer period of time, as well as body composition and fat percentage of 
total body weight could help to determine the underlying mechanisms for this 
observation. Future studies should also include the measurement of neonatal weight in 
both male and female F1 in addition to weeks 3, 4, and 5 p.n., which was shown in the 
Results section, and correlate this with placental weight of control P0 females that were 
mated with either nicotine-exposed or control P0 males. 
Our study, overall, has laid the groundwork for a well-defined experimental design and a 
clean read-out in order to investigate intergenerational effects and phenotypes.  
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